[
  {
    "bcr_patient_uuid": "a6003b1c-56a9-430a-a5e2-b70af3f81bdb",
    "patient_ID": "TCGA.BL.A0C8",
    "bcr_drug_barcode": "TCGA-BL-A0C8-D32669",
    "bcr_drug_uuid": "CC079D30-D4A6-473B-ACCC-8167CA062261",
    "form_completion_date": "2012-6-13",
    "pharmaceutical_therapy_drug_name": "BCG",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 680,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 722,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ebedab7c-dd7c-448e-8324-78c86f13be8b",
    "patient_ID": "TCGA.BT.A20N",
    "bcr_drug_barcode": "TCGA-BT-A20N-D44812",
    "bcr_drug_uuid": "C5775BA6-A233-4EF4-B47C-9C5F34A26DB8",
    "form_completion_date": "2013-6-27",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ebedab7c-dd7c-448e-8324-78c86f13be8b",
    "patient_ID": "TCGA.BT.A20N",
    "bcr_drug_barcode": "TCGA-BT-A20N-D44813",
    "bcr_drug_uuid": "E926C775-6E1D-4366-9740-C919D36E9569",
    "form_completion_date": "2013-6-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 198,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 323,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "096b4f32-10c1-4737-a0dd-cae04c54ee33",
    "patient_ID": "TCGA.BT.A20T",
    "bcr_drug_barcode": "TCGA-BT-A20T-D44883",
    "bcr_drug_uuid": "EEE09E52-7699-40FF-BC3C-8F4EC8F10A18",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 263,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "096b4f32-10c1-4737-a0dd-cae04c54ee33",
    "patient_ID": "TCGA.BT.A20T",
    "bcr_drug_barcode": "TCGA-BT-A20T-D44884",
    "bcr_drug_uuid": "599CD847-F63B-4AD2-84AC-4699DF3DFF12",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 263,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "096b4f32-10c1-4737-a0dd-cae04c54ee33",
    "patient_ID": "TCGA.BT.A20T",
    "bcr_drug_barcode": "TCGA-BT-A20T-D44886",
    "bcr_drug_uuid": "5D769B70-A269-485A-9A41-53B85FCE51AA",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "096b4f32-10c1-4737-a0dd-cae04c54ee33",
    "patient_ID": "TCGA.BT.A20T",
    "bcr_drug_barcode": "TCGA-BT-A20T-D44887",
    "bcr_drug_uuid": "52004135-3449-4E37-8287-0752F6BFCD19",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "OXALIPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "096b4f32-10c1-4737-a0dd-cae04c54ee33",
    "patient_ID": "TCGA.BT.A20T",
    "bcr_drug_barcode": "TCGA-BT-A20T-D44888",
    "bcr_drug_uuid": "F569D2B8-AD43-41C9-8529-8435E1DE6319",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 419,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 419,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "797A71EE-372D-41E5-AEEE-5AB3C4661110",
    "patient_ID": "TCGA.BT.A2LA",
    "bcr_drug_barcode": "TCGA-BT-A2LA-D44911",
    "bcr_drug_uuid": "6350D8AB-C844-4B7E-B614-DFD7938FB5BD",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "797A71EE-372D-41E5-AEEE-5AB3C4661110",
    "patient_ID": "TCGA.BT.A2LA",
    "bcr_drug_barcode": "TCGA-BT-A2LA-D44913",
    "bcr_drug_uuid": "904A4772-EDFC-4C8F-9DF8-14144E3C0AEF",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "ETOPSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 96,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 180,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9DD97821-7AFD-4982-8B1D-F14F845B79F7",
    "patient_ID": "TCGA.BT.A2LD",
    "bcr_drug_barcode": "TCGA-BT-A2LD-D44921",
    "bcr_drug_uuid": "128128BF-D5E7-48BF-ACDB-05921F2B99F5",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 458,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 611,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9DD97821-7AFD-4982-8B1D-F14F845B79F7",
    "patient_ID": "TCGA.BT.A2LD",
    "bcr_drug_barcode": "TCGA-BT-A2LD-D44922",
    "bcr_drug_uuid": "60CACF08-2DDB-465D-B22A-E4A02C79D163",
    "form_completion_date": "2013-6-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 458,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 611,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A",
    "patient_ID": "TCGA.BT.A3PJ",
    "bcr_drug_barcode": "TCGA-BT-A3PJ-D33531",
    "bcr_drug_uuid": "192556C7-0786-4847-9F1B-1CAE6B5215FA",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CB664EEF-BE6F-44EF-AA90-6F6DA0E6440A",
    "patient_ID": "TCGA.BT.A3PJ",
    "bcr_drug_barcode": "TCGA-BT-A3PJ-D33532",
    "bcr_drug_uuid": "6FBBE6F8-44E3-44DA-870D-E15A2A41C7ED",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DB84C62D-6904-4EA8-8E51-1262B8D6FF90",
    "patient_ID": "TCGA.BT.A42B",
    "bcr_drug_barcode": "TCGA-BT-A42B-D42491",
    "bcr_drug_uuid": "ADBAB3EA-7337-4FCC-9C10-E070E6D14AD5",
    "form_completion_date": "2013-4-22",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DB84C62D-6904-4EA8-8E51-1262B8D6FF90",
    "patient_ID": "TCGA.BT.A42B",
    "bcr_drug_barcode": "TCGA-BT-A42B-D42492",
    "bcr_drug_uuid": "66146DE1-BD24-4411-9D76-F0F510B98EA4",
    "form_completion_date": "2013-4-22",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DB84C62D-6904-4EA8-8E51-1262B8D6FF90",
    "patient_ID": "TCGA.BT.A42B",
    "bcr_drug_barcode": "TCGA-BT-A42B-D42493",
    "bcr_drug_uuid": "4ADB46D8-DD6A-4ADB-B16E-54DCC4EE1E69",
    "form_completion_date": "2013-4-22",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 190,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8D434CFB-2414-4D93-BF79-7B957BF040DB",
    "patient_ID": "TCGA.BT.A42E",
    "bcr_drug_barcode": "TCGA-BT-A42E-D50187",
    "bcr_drug_uuid": "59D232F6-DB12-4D16-A157-F88EAB0E2A32",
    "form_completion_date": "2013-10-17",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8D434CFB-2414-4D93-BF79-7B957BF040DB",
    "patient_ID": "TCGA.BT.A42E",
    "bcr_drug_barcode": "TCGA-BT-A42E-D50188",
    "bcr_drug_uuid": "35D81628-2375-4EC8-A6B1-A1AA79E07684",
    "form_completion_date": "2013-10-17",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 49,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 154,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "05935f1d-77c2-46ca-b87a-7a84bce38afd",
    "patient_ID": "TCGA.C4.A0EZ",
    "bcr_drug_barcode": "TCGA-C4-A0EZ-D35652",
    "bcr_drug_uuid": "FA22598C-5DC7-4CC0-B126-B61778FC9C6A",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "05935f1d-77c2-46ca-b87a-7a84bce38afd",
    "patient_ID": "TCGA.C4.A0EZ",
    "bcr_drug_barcode": "TCGA-C4-A0EZ-D35654",
    "bcr_drug_uuid": "4F972928-7DC0-4105-9EDB-736DE4C98E58",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 123,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 212,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "05935f1d-77c2-46ca-b87a-7a84bce38afd",
    "patient_ID": "TCGA.C4.A0EZ",
    "bcr_drug_barcode": "TCGA-C4-A0EZ-D35655",
    "bcr_drug_uuid": "0FD0C954-A1F7-4E90-9E6C-E8BF11419D64",
    "form_completion_date": "2012-12-5",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 243,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D2DF20D4-6704-41E6-B33D-616225BD737C",
    "patient_ID": "TCGA.CF.A47S",
    "bcr_drug_barcode": "TCGA-CF-A47S-D58097",
    "bcr_drug_uuid": "1FD4DDD8-1A40-41E2-8205-C2D3D867EA24",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "BACILLUS CALMETTE-GUERIN (BCG)",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 317,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D2DF20D4-6704-41E6-B33D-616225BD737C",
    "patient_ID": "TCGA.CF.A47S",
    "bcr_drug_barcode": "TCGA-CF-A47S-D58099",
    "bcr_drug_uuid": "A24892D9-7521-435D-BD2F-26048C87B600",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "DOXOBUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 109,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 324,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DB0F02F-94F5-492F-8840-5254792F6879",
    "patient_ID": "TCGA.CF.A47T",
    "bcr_drug_barcode": "TCGA-CF-A47T-D58104",
    "bcr_drug_uuid": "ABE51B78-4B56-45F8-8215-649E93F7FC88",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DB0F02F-94F5-492F-8840-5254792F6879",
    "patient_ID": "TCGA.CF.A47T",
    "bcr_drug_barcode": "TCGA-CF-A47T-D58105",
    "bcr_drug_uuid": "9DE2F76A-A905-4792-8303-AB37F3EE90AB",
    "form_completion_date": "2014-3-31",
    "pharmaceutical_therapy_drug_name": "5FU",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 149,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "087A7F70-2FA8-4A16-B130-4DF10A70C662",
    "patient_ID": "TCGA.CU.A3YL",
    "bcr_drug_barcode": "TCGA-CU-A3YL-D35300",
    "bcr_drug_uuid": "1A2FAC2C-0FAC-4B89-B634-1FC9392C9FFF",
    "form_completion_date": "2012-9-24",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "087A7F70-2FA8-4A16-B130-4DF10A70C662",
    "patient_ID": "TCGA.CU.A3YL",
    "bcr_drug_barcode": "TCGA-CU-A3YL-D35301",
    "bcr_drug_uuid": "9EE4E1B8-45DB-43B7-BE7B-42EE9CF40FD7",
    "form_completion_date": "2012-9-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 155,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 224,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3ed614e7-f356-4d87-985b-d3bbbae3bb40",
    "patient_ID": "TCGA.DK.A1A7",
    "bcr_drug_barcode": "TCGA-DK-A1A7-D21686",
    "bcr_drug_uuid": "ECA9F2E1-28D8-42C3-8F24-30AAB28F9E35",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1300
  },
  {
    "bcr_patient_uuid": "3ed614e7-f356-4d87-985b-d3bbbae3bb40",
    "patient_ID": "TCGA.DK.A1A7",
    "bcr_drug_barcode": "TCGA-DK-A1A7-D72496",
    "bcr_drug_uuid": "CEC69360-02B7-4FDE-9BCB-E92657C2E258",
    "form_completion_date": "2015-7-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 133,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "56d8a1b8-1268-4362-a7f1-77b76fbf1b59",
    "patient_ID": "TCGA.DK.A1AA",
    "bcr_drug_barcode": "TCGA-DK-A1AA-D21689",
    "bcr_drug_uuid": "D2751EF3-82D8-4D53-B419-0CEABE075099",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 92,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 153,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT"
  },
  {
    "bcr_patient_uuid": "f027d254-ec01-4882-a8a7-964ae90b7d49",
    "patient_ID": "TCGA.DK.A1AB",
    "bcr_drug_barcode": "TCGA-DK-A1AB-D21694",
    "bcr_drug_uuid": "007C4BCC-890D-4D72-8668-29EEC0F26562",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "36c14e9d-1863-4c55-bbbb-f8c9dd418932",
    "patient_ID": "TCGA.DK.A1AC",
    "bcr_drug_barcode": "TCGA-DK-A1AC-D21697",
    "bcr_drug_uuid": "D994614A-7BF2-48F5-BE7B-8AE9703EE379",
    "form_completion_date": "2012-2-15",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 168,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "drug_cycles": 4,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 1000,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "ADJUVANT",
    "drug_total_dose": 129
  },
  {
    "bcr_patient_uuid": "36c14e9d-1863-4c55-bbbb-f8c9dd418932",
    "patient_ID": "TCGA.DK.A1AC",
    "bcr_drug_barcode": "TCGA-DK-A1AC-D72501",
    "bcr_drug_uuid": "7F75EDEF-455B-4FBE-A354-E37576C31487",
    "form_completion_date": "2015-7-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 178,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 242,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "88a521ce-a5e9-4c6f-83d4-ec36a62fedb6",
    "patient_ID": "TCGA.DK.A1AD",
    "bcr_drug_barcode": "TCGA-DK-A1AD-D21700",
    "bcr_drug_uuid": "AB32B388-EBBB-4200-B5BC-4997074C81AD",
    "form_completion_date": "2012-2-16"
  },
  {
    "bcr_patient_uuid": "f3104468-bf17-434b-8a7e-bc3b253121ea",
    "patient_ID": "TCGA.DK.A1AF",
    "bcr_drug_barcode": "TCGA-DK-A1AF-D21714",
    "bcr_drug_uuid": "089CDB21-384B-4FB8-8630-778116D6187E",
    "form_completion_date": "2012-2-17",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 289,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 435,
    "drug_cycles": 6,
    "drug_units": "MG/M2",
    "drug_tota_dose_units": "MG",
    "drug_dose": 800,
    "drug_route": "INTRAVENOUS",
    "therapy_regimen": "PROGRESSION",
    "drug_total_dose": 1200
  },
  {
    "bcr_patient_uuid": "E44F60EC-66C4-45A2-A003-0A1FAF1D6E03",
    "patient_ID": "TCGA.DK.A3IQ",
    "bcr_drug_barcode": "TCGA-DK-A3IQ-D38697",
    "bcr_drug_uuid": "FEA4C980-10BE-4F36-9C2F-B2F48E8007A1",
    "form_completion_date": "2012-12-20",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 319,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E44F60EC-66C4-45A2-A003-0A1FAF1D6E03",
    "patient_ID": "TCGA.DK.A3IQ",
    "bcr_drug_barcode": "TCGA-DK-A3IQ-D38698",
    "bcr_drug_uuid": "70BA0E25-A08A-4327-B527-C11B8935C88E",
    "form_completion_date": "2012-12-20",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 277,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 417,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F093F043-EFD4-4CBA-A87F-8CBB5C1ACD9E",
    "patient_ID": "TCGA.DK.A3IU",
    "bcr_drug_barcode": "TCGA-DK-A3IU-D38824",
    "bcr_drug_uuid": "A2C1A3DA-2C5B-4B1E-BE7A-4FED623CA6EF",
    "form_completion_date": "2012-12-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 521,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 578,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F093F043-EFD4-4CBA-A87F-8CBB5C1ACD9E",
    "patient_ID": "TCGA.DK.A3IU",
    "bcr_drug_barcode": "TCGA-DK-A3IU-D38825",
    "bcr_drug_uuid": "F3DF4793-4AAA-4016-B88B-2797DCD1D9E0",
    "form_completion_date": "2012-12-27",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 521,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 578,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F953DC5D-58BF-4936-B9FE-74B45E8C00E5",
    "patient_ID": "TCGA.DK.A3IV",
    "bcr_drug_barcode": "TCGA-DK-A3IV-D38827",
    "bcr_drug_uuid": "162913EB-0994-47A2-950C-E51ABFA2A821",
    "form_completion_date": "2012-12-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F953DC5D-58BF-4936-B9FE-74B45E8C00E5",
    "patient_ID": "TCGA.DK.A3IV",
    "bcr_drug_barcode": "TCGA-DK-A3IV-D38830",
    "bcr_drug_uuid": "8CEBEFB0-57C2-4AB5-9120-A03E28ECB960",
    "form_completion_date": "2012-12-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 17,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 87,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2AB0FB7B-AD2A-403D-9411-712974CCD878",
    "patient_ID": "TCGA.DK.A3WW",
    "bcr_drug_barcode": "TCGA-DK-A3WW-D34647",
    "bcr_drug_uuid": "17EF6B8E-713B-4960-9A68-37EC4E2F805F",
    "form_completion_date": "2012-8-31",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2AB0FB7B-AD2A-403D-9411-712974CCD878",
    "patient_ID": "TCGA.DK.A3WW",
    "bcr_drug_barcode": "TCGA-DK-A3WW-D38323",
    "bcr_drug_uuid": "04EE4CC6-7324-447B-97B9-BE0341C3CD10",
    "form_completion_date": "2012-12-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2AB0FB7B-AD2A-403D-9411-712974CCD878",
    "patient_ID": "TCGA.DK.A3WW",
    "bcr_drug_barcode": "TCGA-DK-A3WW-D38324",
    "bcr_drug_uuid": "2BCC635F-253A-462B-BDCA-6F75B56D0570",
    "form_completion_date": "2012-12-13",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D63C186D-ADD6-492E-8250-E83F46D39D00",
    "patient_ID": "TCGA.DK.A3WX",
    "bcr_drug_barcode": "TCGA-DK-A3WX-D34802",
    "bcr_drug_uuid": "1523238C-7C7D-44D4-951C-3859EA70468B",
    "form_completion_date": "2012-8-31",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D63C186D-ADD6-492E-8250-E83F46D39D00",
    "patient_ID": "TCGA.DK.A3WX",
    "bcr_drug_barcode": "TCGA-DK-A3WX-D38325",
    "bcr_drug_uuid": "9AE90D8B-3ABA-415D-8B04-3BAF436820EC",
    "form_completion_date": "2012-12-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 105,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9BB5D187-033E-4E86-A76E-E1A6D20488F7",
    "patient_ID": "TCGA.DK.A3WY",
    "bcr_drug_barcode": "TCGA-DK-A3WY-D34806",
    "bcr_drug_uuid": "4A25FB83-75D4-4072-AC09-BE58DBE9C8B2",
    "form_completion_date": "2012-8-31",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "9BB5D187-033E-4E86-A76E-E1A6D20488F7",
    "patient_ID": "TCGA.DK.A3WY",
    "bcr_drug_barcode": "TCGA-DK-A3WY-D38326",
    "bcr_drug_uuid": "45EF4B2A-939C-4B66-8309-CCC91660646F",
    "form_completion_date": "2012-12-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 132,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 235,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "10C825D7-4E21-43E7-AC95-DDA75FBDAF74",
    "patient_ID": "TCGA.DK.A6B2",
    "bcr_drug_barcode": "TCGA-DK-A6B2-D48134",
    "bcr_drug_uuid": "8854B40F-584C-4AF1-8488-7BA61B50B207",
    "form_completion_date": "2013-9-6",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 283,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 370,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5E8D936-40AE-4FD3-B40E-CAC54763D71F",
    "patient_ID": "TCGA.DK.A6B5",
    "bcr_drug_barcode": "TCGA-DK-A6B5-D48137",
    "bcr_drug_uuid": "3FFFF824-C57F-4100-B504-E0672D3D9F66",
    "form_completion_date": "2013-9-6",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5E8D936-40AE-4FD3-B40E-CAC54763D71F",
    "patient_ID": "TCGA.DK.A6B5",
    "bcr_drug_barcode": "TCGA-DK-A6B5-D48138",
    "bcr_drug_uuid": "320A8318-5E26-41D8-963A-11D88542F86E",
    "form_completion_date": "2013-9-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D5E8D936-40AE-4FD3-B40E-CAC54763D71F",
    "patient_ID": "TCGA.DK.A6B5",
    "bcr_drug_barcode": "TCGA-DK-A6B5-D48139",
    "bcr_drug_uuid": "E15A97F1-68D6-4A22-B69E-50AD72C91B7A",
    "form_completion_date": "2013-9-6",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 248,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AB6580E4-5DE9-4361-B06A-1D20E5571890",
    "patient_ID": "TCGA.DK.A6B6",
    "bcr_drug_barcode": "TCGA-DK-A6B6-D48127",
    "bcr_drug_uuid": "2041396B-C7B9-41E9-A0AE-8535D21FC31F",
    "form_completion_date": "2013-9-6",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AB6580E4-5DE9-4361-B06A-1D20E5571890",
    "patient_ID": "TCGA.DK.A6B6",
    "bcr_drug_barcode": "TCGA-DK-A6B6-D48128",
    "bcr_drug_uuid": "E1F69D35-AE98-483D-88E3-1F82EFE74FBE",
    "form_completion_date": "2013-9-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 43,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 113,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D8B07FDD-5580-4BCC-9619-B5E0C9F0AA3D",
    "patient_ID": "TCGA.DK.AA6M",
    "bcr_drug_barcode": "TCGA-DK-AA6M-D69746",
    "bcr_drug_uuid": "C63CB31F-1C6B-4766-B1FE-AF1DDC37383F",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "days_to_drug_start": 735,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 820,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D8B07FDD-5580-4BCC-9619-B5E0C9F0AA3D",
    "patient_ID": "TCGA.DK.AA6M",
    "bcr_drug_barcode": "TCGA-DK-AA6M-D69747",
    "bcr_drug_uuid": "8A269839-4BD4-49AD-AEAB-2A02D841044E",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 735,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 820,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4E702CA1-C0E0-4B9C-B9C7-7D7946818561",
    "patient_ID": "TCGA.DK.AA6P",
    "bcr_drug_barcode": "TCGA-DK-AA6P-D69748",
    "bcr_drug_uuid": "867D9644-9CE9-4F05-BCBE-E98A5C12FF94",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4E702CA1-C0E0-4B9C-B9C7-7D7946818561",
    "patient_ID": "TCGA.DK.AA6P",
    "bcr_drug_barcode": "TCGA-DK-AA6P-D69749",
    "bcr_drug_uuid": "A2C44B1C-D97E-4BEE-B533-447B609EE994",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "days_to_drug_start": 27,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 99,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5DB4B168-A6BA-482C-B067-2274EBA96AAD",
    "patient_ID": "TCGA.DK.AA6R",
    "bcr_drug_barcode": "TCGA-DK-AA6R-D69751",
    "bcr_drug_uuid": "AF28FF1A-7607-4AB9-9180-D0292F8ED1B4",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5DB4B168-A6BA-482C-B067-2274EBA96AAD",
    "patient_ID": "TCGA.DK.AA6R",
    "bcr_drug_barcode": "TCGA-DK-AA6R-D69752",
    "bcr_drug_uuid": "C2AD34E8-BC09-455E-ADB8-C2AB3537251F",
    "form_completion_date": "2015-1-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 125,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 204,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45EEA556-E97B-4912-8AA9-7E5C709EB52B",
    "patient_ID": "TCGA.DK.AA6S",
    "bcr_drug_barcode": "TCGA-DK-AA6S-D65595",
    "bcr_drug_uuid": "7C12264A-4248-4E62-A2D8-8019A6B747EC",
    "form_completion_date": "2014-9-25",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 575,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 710,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45EEA556-E97B-4912-8AA9-7E5C709EB52B",
    "patient_ID": "TCGA.DK.AA6S",
    "bcr_drug_barcode": "TCGA-DK-AA6S-D65596",
    "bcr_drug_uuid": "4E8F6A0C-588C-4FCA-BA02-BCA414A7E257",
    "form_completion_date": "2014-9-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 575,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 710,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "45EEA556-E97B-4912-8AA9-7E5C709EB52B",
    "patient_ID": "TCGA.DK.AA6S",
    "bcr_drug_barcode": "TCGA-DK-AA6S-D65597",
    "bcr_drug_uuid": "E8070EE0-F024-4531-984D-F82E332BC4F7",
    "form_completion_date": "2014-9-25",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 575,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 710,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9B55748-605A-4313-BB19-DCF5476590C2",
    "patient_ID": "TCGA.DK.AA6T",
    "bcr_drug_barcode": "TCGA-DK-AA6T-D72250",
    "bcr_drug_uuid": "E005F128-2354-4914-9820-1D7061766112",
    "form_completion_date": "2015-4-30",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9B55748-605A-4313-BB19-DCF5476590C2",
    "patient_ID": "TCGA.DK.AA6T",
    "bcr_drug_barcode": "TCGA-DK-AA6T-D72251",
    "bcr_drug_uuid": "A8580409-6B13-4526-9A0B-34C7ADACFC66",
    "form_completion_date": "2015-4-30",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 75,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 110,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "104C8E20-1B29-4D77-9633-359A35BE48FB",
    "patient_ID": "TCGA.DK.AA6U",
    "bcr_drug_barcode": "TCGA-DK-AA6U-D72252",
    "bcr_drug_uuid": "8717DA3C-6BC0-43D9-8B8E-D0A7544AC307",
    "form_completion_date": "2015-4-30",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "104C8E20-1B29-4D77-9633-359A35BE48FB",
    "patient_ID": "TCGA.DK.AA6U",
    "bcr_drug_barcode": "TCGA-DK-AA6U-D72253",
    "bcr_drug_uuid": "19EFBAA9-333A-453F-A8D4-0CC510265974",
    "form_completion_date": "2015-4-30",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 13,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 90,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "63FA8434-4A6F-4C32-9C5D-89DCC913900B",
    "patient_ID": "TCGA.DK.AA6W",
    "bcr_drug_barcode": "TCGA-DK-AA6W-D72254",
    "bcr_drug_uuid": "C345C9A2-9EBB-4498-BB87-A5062A9E9F5C",
    "form_completion_date": "2015-4-30",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 263,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 328,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D37B0460-EFA4-4CF5-8082-F27FF2CF2F28",
    "patient_ID": "TCGA.DK.AA76",
    "bcr_drug_barcode": "TCGA-DK-AA76-D61822",
    "bcr_drug_uuid": "463A618D-7086-4797-BF6E-5AB843256101",
    "form_completion_date": "2014-7-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D37B0460-EFA4-4CF5-8082-F27FF2CF2F28",
    "patient_ID": "TCGA.DK.AA76",
    "bcr_drug_barcode": "TCGA-DK-AA76-D61823",
    "bcr_drug_uuid": "1773BFBE-9FA4-44A0-AE26-0699056C9968",
    "form_completion_date": "2014-7-8",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 54,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EB4F8C76-08D9-4BA4-846E-969FDED63A87",
    "patient_ID": "TCGA.DK.AA77",
    "bcr_drug_barcode": "TCGA-DK-AA77-D71291",
    "bcr_drug_uuid": "F449613B-5D29-4046-B813-CE6027B59AC9",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "IPILIMUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 601,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "EB4F8C76-08D9-4BA4-846E-969FDED63A87",
    "patient_ID": "TCGA.DK.AA77",
    "bcr_drug_barcode": "TCGA-DK-AA77-D71292",
    "bcr_drug_uuid": "14E324EF-5C14-41E0-9F64-8A2BB52381EA",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "NIVOLUMAB",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 601,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "4107AE6F-502C-4BDC-BF14-E4B3711CBA38",
    "patient_ID": "TCGA.E5.A2PC",
    "bcr_drug_barcode": "TCGA-E5-A2PC-D33522",
    "bcr_drug_uuid": "840DE356-7316-43B4-B965-CB0211FE9A6D",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4107AE6F-502C-4BDC-BF14-E4B3711CBA38",
    "patient_ID": "TCGA.E5.A2PC",
    "bcr_drug_barcode": "TCGA-E5-A2PC-D33523",
    "bcr_drug_uuid": "9D582767-B547-411F-9EC9-E5DD43A53072",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4107AE6F-502C-4BDC-BF14-E4B3711CBA38",
    "patient_ID": "TCGA.E5.A2PC",
    "bcr_drug_barcode": "TCGA-E5-A2PC-D33524",
    "bcr_drug_uuid": "EA31A3BA-4FDF-4FBB-8B12-C9B82B0E0FF1",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4107AE6F-502C-4BDC-BF14-E4B3711CBA38",
    "patient_ID": "TCGA.E5.A2PC",
    "bcr_drug_barcode": "TCGA-E5-A2PC-D33525",
    "bcr_drug_uuid": "66F39A5C-1A16-4EA3-B226-E2BFEC047106",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 139,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CA6403DD-3BD5-4023-8EA1-9957EC44DBA5",
    "patient_ID": "TCGA.E5.A4TZ",
    "bcr_drug_barcode": "TCGA-E5-A4TZ-D46813",
    "bcr_drug_uuid": "2FC8F65C-99BA-4FD3-9FA6-49BA92055C8D",
    "form_completion_date": "2013-8-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CA6403DD-3BD5-4023-8EA1-9957EC44DBA5",
    "patient_ID": "TCGA.E5.A4TZ",
    "bcr_drug_barcode": "TCGA-E5-A4TZ-D46814",
    "bcr_drug_uuid": "157CE8C2-724C-41E7-B869-6415366AFD56",
    "form_completion_date": "2013-8-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 421,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1C28F311-E0B0-4292-B29A-C6757665A4A4",
    "patient_ID": "TCGA.E5.A4U1",
    "bcr_drug_barcode": "TCGA-E5-A4U1-D46817",
    "bcr_drug_uuid": "96872F51-C5BA-45CD-AC97-732ECD1C7882",
    "form_completion_date": "2013-8-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1C28F311-E0B0-4292-B29A-C6757665A4A4",
    "patient_ID": "TCGA.E5.A4U1",
    "bcr_drug_barcode": "TCGA-E5-A4U1-D46818",
    "bcr_drug_uuid": "EEFCDB26-883B-464B-B5C0-E853A005B064",
    "form_completion_date": "2013-8-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 37,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 114,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1C28F311-E0B0-4292-B29A-C6757665A4A4",
    "patient_ID": "TCGA.E5.A4U1",
    "bcr_drug_barcode": "TCGA-E5-A4U1-D46819",
    "bcr_drug_uuid": "2C0679DA-9E80-4991-AB18-1F46BE8D7043",
    "form_completion_date": "2013-8-19",
    "clinical_trial_drug_classification": "PLATINUM-BASED ANTINEOPLASTIC",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 719,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "1C28F311-E0B0-4292-B29A-C6757665A4A4",
    "patient_ID": "TCGA.E5.A4U1",
    "bcr_drug_barcode": "TCGA-E5-A4U1-D64526",
    "bcr_drug_uuid": "5E9878DB-0C67-4111-A7A8-3D3A8F797097",
    "form_completion_date": "2014-9-4",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1024,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1150,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "899F8D52-4C3A-4371-90EB-1F106001EDDC",
    "patient_ID": "TCGA.FD.A3B4",
    "bcr_drug_barcode": "TCGA-FD-A3B4-D35160",
    "bcr_drug_uuid": "5940A678-2FBC-4D43-B89A-5C9260706B92",
    "form_completion_date": "2012-9-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "899F8D52-4C3A-4371-90EB-1F106001EDDC",
    "patient_ID": "TCGA.FD.A3B4",
    "bcr_drug_barcode": "TCGA-FD-A3B4-D35162",
    "bcr_drug_uuid": "335EC112-7819-4AB3-9F92-8D4B664F4300",
    "form_completion_date": "2012-9-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 115,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 157,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D8D8169-0C1A-4CDB-BE6F-9761C981A369",
    "patient_ID": "TCGA.FD.A3SJ",
    "bcr_drug_barcode": "TCGA-FD-A3SJ-D33690",
    "bcr_drug_uuid": "D46CF87F-BDB1-4A91-A6E9-DC55A849448A",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 401,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 436,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D8D8169-0C1A-4CDB-BE6F-9761C981A369",
    "patient_ID": "TCGA.FD.A3SJ",
    "bcr_drug_barcode": "TCGA-FD-A3SJ-D33689",
    "bcr_drug_uuid": "2F5A329A-927F-442B-B822-D3FEE2DC0652",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 315,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 436,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D8D8169-0C1A-4CDB-BE6F-9761C981A369",
    "patient_ID": "TCGA.FD.A3SJ",
    "bcr_drug_barcode": "TCGA-FD-A3SJ-D33686",
    "bcr_drug_uuid": "29A19447-3D72-4510-B886-5FCB0CA749EC",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D8D8169-0C1A-4CDB-BE6F-9761C981A369",
    "patient_ID": "TCGA.FD.A3SJ",
    "bcr_drug_barcode": "TCGA-FD-A3SJ-D33687",
    "bcr_drug_uuid": "18F7755E-C287-409E-9372-DD03A9A5645D",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D8D8169-0C1A-4CDB-BE6F-9761C981A369",
    "patient_ID": "TCGA.FD.A3SJ",
    "bcr_drug_barcode": "TCGA-FD-A3SJ-D33688",
    "bcr_drug_uuid": "9F42AC4D-A0A4-4F5D-B058-D06F76527AD7",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 380,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6D8D8169-0C1A-4CDB-BE6F-9761C981A369",
    "patient_ID": "TCGA.FD.A3SJ",
    "bcr_drug_barcode": "TCGA-FD-A3SJ-D33648",
    "bcr_drug_uuid": "10D93D30-4AC6-484F-8772-54A424C9799B",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 274,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 275,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4570B6E2-D430-41CA-AAB1-CE4D14C36463",
    "patient_ID": "TCGA.FD.A3SL",
    "bcr_drug_barcode": "TCGA-FD-A3SL-D33649",
    "bcr_drug_uuid": "BB25DB8B-51F1-4153-ABE2-B39BD289CCE7",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 302,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4570B6E2-D430-41CA-AAB1-CE4D14C36463",
    "patient_ID": "TCGA.FD.A3SL",
    "bcr_drug_barcode": "TCGA-FD-A3SL-D33756",
    "bcr_drug_uuid": "EED1ECB8-D31C-45AA-AE8F-096151C2119B",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 302,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0",
    "patient_ID": "TCGA.FD.A3SN",
    "bcr_drug_barcode": "TCGA-FD-A3SN-D33683",
    "bcr_drug_uuid": "45258132-2CEA-49CB-AE98-AC10A19FBE4F",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0FB043D3-D86B-4CD8-8C01-9E2B3E965BB0",
    "patient_ID": "TCGA.FD.A3SN",
    "bcr_drug_barcode": "TCGA-FD-A3SN-D33651",
    "bcr_drug_uuid": "EE5DDF30-665A-41D3-B2F7-DF00A66F9AF7",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 117,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "94809FBF-4895-42C0-A7C6-F39EE1A41F1A",
    "patient_ID": "TCGA.FD.A3SO",
    "bcr_drug_barcode": "TCGA-FD-A3SO-D33761",
    "bcr_drug_uuid": "9B5A5F82-649E-4766-9335-08E0AB8066EF",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 65,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "94809FBF-4895-42C0-A7C6-F39EE1A41F1A",
    "patient_ID": "TCGA.FD.A3SO",
    "bcr_drug_barcode": "TCGA-FD-A3SO-D33762",
    "bcr_drug_uuid": "AD1913FA-7D64-48EC-8466-E69C289C73EA",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 66,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 141,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F99DCFF-D809-4C87-8024-C9B30BD565E9",
    "patient_ID": "TCGA.FD.A3SP",
    "bcr_drug_barcode": "TCGA-FD-A3SP-D33682",
    "bcr_drug_uuid": "EC4345EC-ED68-4CC4-A3D2-FCC1D18496EE",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F99DCFF-D809-4C87-8024-C9B30BD565E9",
    "patient_ID": "TCGA.FD.A3SP",
    "bcr_drug_barcode": "TCGA-FD-A3SP-D33681",
    "bcr_drug_uuid": "A32E7CE7-B4D1-41E0-AF63-C26330A75697",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F99DCFF-D809-4C87-8024-C9B30BD565E9",
    "patient_ID": "TCGA.FD.A3SP",
    "bcr_drug_barcode": "TCGA-FD-A3SP-D33680",
    "bcr_drug_uuid": "A064C5AC-02E1-47FB-9C5E-5C17018C8E74",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5F99DCFF-D809-4C87-8024-C9B30BD565E9",
    "patient_ID": "TCGA.FD.A3SP",
    "bcr_drug_barcode": "TCGA-FD-A3SP-D33652",
    "bcr_drug_uuid": "4BE7B781-6C12-4067-B136-2724AB31EFAE",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 62,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF",
    "patient_ID": "TCGA.FD.A3SQ",
    "bcr_drug_barcode": "TCGA-FD-A3SQ-D33675",
    "bcr_drug_uuid": "81447471-FB3B-4D05-B527-98E45F069D2B",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3071CB51-DCF5-41F7-B047-AFC2DCBF0AAF",
    "patient_ID": "TCGA.FD.A3SQ",
    "bcr_drug_barcode": "TCGA-FD-A3SQ-D33653",
    "bcr_drug_uuid": "8D7B7DDD-FDC7-4951-B8A2-445454530940",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 78,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "72D6E9AA-4A99-4FC9-A67B-4631E95FB043",
    "patient_ID": "TCGA.FD.A3SR",
    "bcr_drug_barcode": "TCGA-FD-A3SR-D33654",
    "bcr_drug_uuid": "9C56F2E6-F86F-4A57-9158-0793C716E037",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 244,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "72D6E9AA-4A99-4FC9-A67B-4631E95FB043",
    "patient_ID": "TCGA.FD.A3SR",
    "bcr_drug_barcode": "TCGA-FD-A3SR-D33754",
    "bcr_drug_uuid": "FD615382-1046-48B0-B4E1-13B62563CA35",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 146,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 244,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7B98B829-FDC7-4719-BEE9-C83F6154019C",
    "patient_ID": "TCGA.FD.A3SS",
    "bcr_drug_barcode": "TCGA-FD-A3SS-D33752",
    "bcr_drug_uuid": "CED740F1-EA01-4484-86E5-C70E0A8F09D6",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7B98B829-FDC7-4719-BEE9-C83F6154019C",
    "patient_ID": "TCGA.FD.A3SS",
    "bcr_drug_barcode": "TCGA-FD-A3SS-D33753",
    "bcr_drug_uuid": "8668A690-F52F-42C2-92BF-02C09FA20491",
    "form_completion_date": "2012-7-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 87,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77236911-D9E0-4B85-829A-A98F1E4B92D2",
    "patient_ID": "TCGA.FD.A43S",
    "bcr_drug_barcode": "TCGA-FD-A43S-D37178",
    "bcr_drug_uuid": "04F50A93-E799-4689-B04D-4ED2F5117807",
    "form_completion_date": "2012-11-29",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "77236911-D9E0-4B85-829A-A98F1E4B92D2",
    "patient_ID": "TCGA.FD.A43S",
    "bcr_drug_barcode": "TCGA-FD-A43S-D37179",
    "bcr_drug_uuid": "4A856656-F609-4E8A-9DC5-FB385BFA1330",
    "form_completion_date": "2012-11-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "140B83DB-BADD-4B8D-B0F5-0F8C8060A228",
    "patient_ID": "TCGA.FD.A43U",
    "bcr_drug_barcode": "TCGA-FD-A43U-D37162",
    "bcr_drug_uuid": "30047ACF-3C71-424A-96A3-91A9B5088E03",
    "form_completion_date": "2012-11-29",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "140B83DB-BADD-4B8D-B0F5-0F8C8060A228",
    "patient_ID": "TCGA.FD.A43U",
    "bcr_drug_barcode": "TCGA-FD-A43U-D37161",
    "bcr_drug_uuid": "1A5B47F2-E3BC-4326-A144-6A2149549E64",
    "form_completion_date": "2012-11-29",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 187,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B581E799-93D1-4F1C-BCB7-7E7AE86A869E",
    "patient_ID": "TCGA.FD.A5BS",
    "bcr_drug_barcode": "TCGA-FD-A5BS-D42843",
    "bcr_drug_uuid": "5EB61728-0F85-4E66-A57A-E18B2A18A99F",
    "form_completion_date": "2013-5-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 777,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 854,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B581E799-93D1-4F1C-BCB7-7E7AE86A869E",
    "patient_ID": "TCGA.FD.A5BS",
    "bcr_drug_barcode": "TCGA-FD-A5BS-D42845",
    "bcr_drug_uuid": "D9E3F149-3C29-49FA-91B5-5BC112FBA477",
    "form_completion_date": "2013-5-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 777,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 854,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0628E443-3D7F-4A38-9D2A-EBC7F4F7E11D",
    "patient_ID": "TCGA.FD.A5C0",
    "bcr_drug_barcode": "TCGA-FD-A5C0-D52786",
    "bcr_drug_uuid": "8E6819B1-FF17-4577-A360-DA93229C7D85",
    "form_completion_date": "2013-12-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 307,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0628E443-3D7F-4A38-9D2A-EBC7F4F7E11D",
    "patient_ID": "TCGA.FD.A5C0",
    "bcr_drug_barcode": "TCGA-FD-A5C0-D66959",
    "bcr_drug_uuid": "88613404-91D6-490E-BD7F-7B1AA3B8861B",
    "form_completion_date": "2014-10-28",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 160,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 279,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "070C66FA-EF48-46CB-AF4F-357D2C641118",
    "patient_ID": "TCGA.FD.A5C1",
    "bcr_drug_barcode": "TCGA-FD-A5C1-D42881",
    "bcr_drug_uuid": "45375F4F-6BC8-465E-98F1-108048498790",
    "form_completion_date": "2013-5-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1421,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1491,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "070C66FA-EF48-46CB-AF4F-357D2C641118",
    "patient_ID": "TCGA.FD.A5C1",
    "bcr_drug_barcode": "TCGA-FD-A5C1-D42882",
    "bcr_drug_uuid": "6E578A68-195F-420D-BE0E-7E95AFF64298",
    "form_completion_date": "2013-5-2",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1421,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1491,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "05A1402E-5A79-4D54-9430-065844ED1505",
    "patient_ID": "TCGA.FD.A62S",
    "bcr_drug_barcode": "TCGA-FD-A62S-D59247",
    "bcr_drug_uuid": "70601C33-808B-4205-B4A0-5E13B0222A74",
    "form_completion_date": "2014-5-6",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 292,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "05A1402E-5A79-4D54-9430-065844ED1505",
    "patient_ID": "TCGA.FD.A62S",
    "bcr_drug_barcode": "TCGA-FD-A62S-D59248",
    "bcr_drug_uuid": "7810A477-A6E8-4F7D-9010-A459ACF20768",
    "form_completion_date": "2014-5-6",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 243,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 292,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FCDA9873-3A93-40B2-913D-4DF1E6A27EFB",
    "patient_ID": "TCGA.FD.A6TA",
    "bcr_drug_barcode": "TCGA-FD-A6TA-D52340",
    "bcr_drug_uuid": "7F99BFE6-098D-42D2-ACF4-4DE6EBCD0CF9",
    "form_completion_date": "2013-12-5",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FCDA9873-3A93-40B2-913D-4DF1E6A27EFB",
    "patient_ID": "TCGA.FD.A6TA",
    "bcr_drug_barcode": "TCGA-FD-A6TA-D68612",
    "bcr_drug_uuid": "53028C3F-EDF0-42BA-B671-46F9CE25945F",
    "form_completion_date": "2014-12-3",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FCDA9873-3A93-40B2-913D-4DF1E6A27EFB",
    "patient_ID": "TCGA.FD.A6TA",
    "bcr_drug_barcode": "TCGA-FD-A6TA-D68613",
    "bcr_drug_uuid": "5ADC65CB-A99A-4D85-BF5E-4ED74495D402",
    "form_completion_date": "2014-12-3",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FCDA9873-3A93-40B2-913D-4DF1E6A27EFB",
    "patient_ID": "TCGA.FD.A6TA",
    "bcr_drug_barcode": "TCGA-FD-A6TA-D68614",
    "bcr_drug_uuid": "3AEE3F5E-6B5D-4567-B3A5-8AD855BB1CD7",
    "form_completion_date": "2014-12-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 55,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 92,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "00D8E96F-F231-4475-9E9F-C1F8AEC28E4E",
    "patient_ID": "TCGA.FD.A6TC",
    "bcr_drug_barcode": "TCGA-FD-A6TC-D65163",
    "bcr_drug_uuid": "D8EC9D40-C854-49D3-A8D3-728EEA56AF35",
    "form_completion_date": "2014-9-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "00D8E96F-F231-4475-9E9F-C1F8AEC28E4E",
    "patient_ID": "TCGA.FD.A6TC",
    "bcr_drug_barcode": "TCGA-FD-A6TC-D68615",
    "bcr_drug_uuid": "A4A05996-848F-40E6-9B5F-A788FE319189",
    "form_completion_date": "2014-12-3",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 88,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 144,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6B2D63F2-F390-4601-9640-F769F6E91BF4",
    "patient_ID": "TCGA.FJ.A3Z7",
    "bcr_drug_barcode": "TCGA-FJ-A3Z7-D35226",
    "bcr_drug_uuid": "47E93333-1850-4C38-8E1D-5A7864798362",
    "form_completion_date": "2012-9-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "6B2D63F2-F390-4601-9640-F769F6E91BF4",
    "patient_ID": "TCGA.FJ.A3Z7",
    "bcr_drug_barcode": "TCGA-FJ-A3Z7-D35227",
    "bcr_drug_uuid": "7DBE2237-5295-4C81-ABB9-B097799A7E3B",
    "form_completion_date": "2012-9-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 70,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 70,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "72FF655F-BB08-40ED-B4C3-E9497D4DA108",
    "patient_ID": "TCGA.FJ.A3Z9",
    "bcr_drug_barcode": "TCGA-FJ-A3Z9-D39901",
    "bcr_drug_uuid": "E9218D07-B328-4398-A40D-51E36F5B70F6",
    "form_completion_date": "2013-2-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 32,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 122,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "72FF655F-BB08-40ED-B4C3-E9497D4DA108",
    "patient_ID": "TCGA.FJ.A3Z9",
    "bcr_drug_barcode": "TCGA-FJ-A3Z9-D39902",
    "bcr_drug_uuid": "62362BC9-BED1-4D5D-A0B2-92104A2AA5BB",
    "form_completion_date": "2013-2-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 46,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 89,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FAE38579-5FE2-4D81-9729-39FDE866D18C",
    "patient_ID": "TCGA.FJ.A3ZF",
    "bcr_drug_barcode": "TCGA-FJ-A3ZF-D35448",
    "bcr_drug_uuid": "915AE1D4-FC2F-435B-A9C0-50399F927849",
    "form_completion_date": "2012-9-28",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FAE38579-5FE2-4D81-9729-39FDE866D18C",
    "patient_ID": "TCGA.FJ.A3ZF",
    "bcr_drug_barcode": "TCGA-FJ-A3ZF-D35449",
    "bcr_drug_uuid": "46DD0CD8-0491-49DE-8BA6-AEA205781F11",
    "form_completion_date": "2012-9-28",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 41,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 104,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB38805E-2CCC-4169-BA01-34B98ADF5BD0",
    "patient_ID": "TCGA.FJ.A871",
    "bcr_drug_barcode": "TCGA-FJ-A871-D56216",
    "bcr_drug_uuid": "4B766531-8A57-4E13-A7A9-A1EC9B1D7F3A",
    "form_completion_date": "2014-2-7",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 91,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB38805E-2CCC-4169-BA01-34B98ADF5BD0",
    "patient_ID": "TCGA.FJ.A871",
    "bcr_drug_barcode": "TCGA-FJ-A871-D56218",
    "bcr_drug_uuid": "108BD781-9598-4C1E-8FE8-D1D61B9C7630",
    "form_completion_date": "2014-2-7",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB38805E-2CCC-4169-BA01-34B98ADF5BD0",
    "patient_ID": "TCGA.FJ.A871",
    "bcr_drug_barcode": "TCGA-FJ-A871-D56219",
    "bcr_drug_uuid": "471F6C0B-5E2C-4A14-93A5-2F1FB12C6B3F",
    "form_completion_date": "2014-2-7",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB38805E-2CCC-4169-BA01-34B98ADF5BD0",
    "patient_ID": "TCGA.FJ.A871",
    "bcr_drug_barcode": "TCGA-FJ-A871-D56221",
    "bcr_drug_uuid": "508CF5FA-BE2F-4FE1-988D-8D8E4B68505B",
    "form_completion_date": "2014-2-7",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 205,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "BB38805E-2CCC-4169-BA01-34B98ADF5BD0",
    "patient_ID": "TCGA.FJ.A871",
    "bcr_drug_barcode": "TCGA-FJ-A871-D56222",
    "bcr_drug_uuid": "1CCD314B-CA6D-4689-BC55-517977BB239F",
    "form_completion_date": "2014-2-7",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 113,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 189,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "28E25FFB-8B0C-4839-A735-ED7B78E3213A",
    "patient_ID": "TCGA.G2.A2EC",
    "bcr_drug_barcode": "TCGA-G2-A2EC-D32966",
    "bcr_drug_uuid": "5F880A8D-BB78-4B6D-93D7-F74316C6BA12",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "AVASTIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "28E25FFB-8B0C-4839-A735-ED7B78E3213A",
    "patient_ID": "TCGA.G2.A2EC",
    "bcr_drug_barcode": "TCGA-G2-A2EC-D32970",
    "bcr_drug_uuid": "FB24E0AB-685D-4F11-BBB4-5B9BF10D1175",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "28E25FFB-8B0C-4839-A735-ED7B78E3213A",
    "patient_ID": "TCGA.G2.A2EC",
    "bcr_drug_barcode": "TCGA-G2-A2EC-D32972",
    "bcr_drug_uuid": "0C042234-F74E-44C6-B315-2AED33B22050",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "28E25FFB-8B0C-4839-A735-ED7B78E3213A",
    "patient_ID": "TCGA.G2.A2EC",
    "bcr_drug_barcode": "TCGA-G2-A2EC-D32974",
    "bcr_drug_uuid": "33CA9D74-59C9-41FF-9CB0-770323D2CEC2",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "28E25FFB-8B0C-4839-A735-ED7B78E3213A",
    "patient_ID": "TCGA.G2.A2EC",
    "bcr_drug_barcode": "TCGA-G2-A2EC-D32976",
    "bcr_drug_uuid": "F177C0BC-4D08-4D17-B546-1B4C4560AC32",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 24,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 75,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "2A142731-119C-495D-AD30-EB0B48BACB46",
    "patient_ID": "TCGA.G2.A2EF",
    "bcr_drug_barcode": "TCGA-G2-A2EF-D32982",
    "bcr_drug_uuid": "694CAEDC-6696-4C04-8FFA-8185A917C637",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "2A142731-119C-495D-AD30-EB0B48BACB46",
    "patient_ID": "TCGA.G2.A2EF",
    "bcr_drug_barcode": "TCGA-G2-A2EF-D32999",
    "bcr_drug_uuid": "CE48C3DC-2CAB-4EA1-BFAE-B2F8A374D129",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "2A142731-119C-495D-AD30-EB0B48BACB46",
    "patient_ID": "TCGA.G2.A2EF",
    "bcr_drug_barcode": "TCGA-G2-A2EF-D33000",
    "bcr_drug_uuid": "6AD678ED-C233-48AB-A30B-A55F7ACA8888",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "2A142731-119C-495D-AD30-EB0B48BACB46",
    "patient_ID": "TCGA.G2.A2EF",
    "bcr_drug_barcode": "TCGA-G2-A2EF-D33001",
    "bcr_drug_uuid": "27866927-5E9F-496E-98E2-383756CF2470",
    "form_completion_date": "2012-6-18",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C6227D39-D9E8-4E28-9E70-D7F720AB25E4",
    "patient_ID": "TCGA.G2.A2EJ",
    "bcr_drug_barcode": "TCGA-G2-A2EJ-D33047",
    "bcr_drug_uuid": "DEDCF85F-17C4-4009-B43B-02B15C96A350",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 38,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C6227D39-D9E8-4E28-9E70-D7F720AB25E4",
    "patient_ID": "TCGA.G2.A2EJ",
    "bcr_drug_barcode": "TCGA-G2-A2EJ-D33048",
    "bcr_drug_uuid": "5DA2805D-F33C-495D-AC31-F558AD5AF82B",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "MESNA",
    "clinical_trial_drug_classification": "CHEMOPROTECTANT",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 38,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C6227D39-D9E8-4E28-9E70-D7F720AB25E4",
    "patient_ID": "TCGA.G2.A2EJ",
    "bcr_drug_barcode": "TCGA-G2-A2EJ-D33049",
    "bcr_drug_uuid": "5EE666E4-D150-4D48-8E5C-AF20E5AF64F2",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 38,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "C6227D39-D9E8-4E28-9E70-D7F720AB25E4",
    "patient_ID": "TCGA.G2.A2EJ",
    "bcr_drug_barcode": "TCGA-G2-A2EJ-D33051",
    "bcr_drug_uuid": "C1846A1C-F3C8-4FEF-B4AC-ABEF8DD94EBE",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 38,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 38,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5DA1CB68-C438-4DDC-999F-90AED0C4BD7A",
    "patient_ID": "TCGA.G2.A2EK",
    "bcr_drug_barcode": "TCGA-G2-A2EK-D33053",
    "bcr_drug_uuid": "BC31F705-AC1F-451C-B617-642C19AC6154",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5DA1CB68-C438-4DDC-999F-90AED0C4BD7A",
    "patient_ID": "TCGA.G2.A2EK",
    "bcr_drug_barcode": "TCGA-G2-A2EK-D33055",
    "bcr_drug_uuid": "6BC25833-7CCC-488D-B705-7D6096D35669",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5DA1CB68-C438-4DDC-999F-90AED0C4BD7A",
    "patient_ID": "TCGA.G2.A2EK",
    "bcr_drug_barcode": "TCGA-G2-A2EK-D33056",
    "bcr_drug_uuid": "C4EB7979-5C32-4875-8828-4EB57A8DD1B8",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5DA1CB68-C438-4DDC-999F-90AED0C4BD7A",
    "patient_ID": "TCGA.G2.A2EK",
    "bcr_drug_barcode": "TCGA-G2-A2EK-D33057",
    "bcr_drug_uuid": "9A57D186-A1F1-4A86-9BE8-3ABE6184F3E0",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 16,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 51,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "30C7445E-D0C4-4A0F-96A4-27E4259EE10B",
    "patient_ID": "TCGA.G2.A2EL",
    "bcr_drug_barcode": "TCGA-G2-A2EL-D33061",
    "bcr_drug_uuid": "CE05EB69-BFCC-4DDE-BBAC-801411756E33",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "ETOPOSIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "30C7445E-D0C4-4A0F-96A4-27E4259EE10B",
    "patient_ID": "TCGA.G2.A2EL",
    "bcr_drug_barcode": "TCGA-G2-A2EL-D33062",
    "bcr_drug_uuid": "46912AB3-5EC9-44D6-A76B-87E4B79BFCA8",
    "form_completion_date": "2012-6-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 84,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 147,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "AF53D51E-0B5C-437F-A1C0-EC5F55C49364",
    "patient_ID": "TCGA.G2.A3IB",
    "bcr_drug_barcode": "TCGA-G2-A3IB-D66245",
    "bcr_drug_uuid": "97C76471-15CA-4401-8DC2-CF41E785A05C",
    "form_completion_date": "2014-10-6",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF53D51E-0B5C-437F-A1C0-EC5F55C49364",
    "patient_ID": "TCGA.G2.A3IB",
    "bcr_drug_barcode": "TCGA-G2-A3IB-D66248",
    "bcr_drug_uuid": "6027EDD0-09D5-4740-BFBB-683474BD2E46",
    "form_completion_date": "2014-10-6",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF53D51E-0B5C-437F-A1C0-EC5F55C49364",
    "patient_ID": "TCGA.G2.A3IB",
    "bcr_drug_barcode": "TCGA-G2-A3IB-D66249",
    "bcr_drug_uuid": "AD2CE47B-EDF1-41B7-A6F5-37EB9F7FA188",
    "form_completion_date": "2014-10-6",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AF53D51E-0B5C-437F-A1C0-EC5F55C49364",
    "patient_ID": "TCGA.G2.A3IB",
    "bcr_drug_barcode": "TCGA-G2-A3IB-D66250",
    "bcr_drug_uuid": "E79E0B30-0DD8-4B1A-A0C0-F8B62FB21AB4",
    "form_completion_date": "2014-10-6",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 143,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB",
    "patient_ID": "TCGA.G2.A3IE",
    "bcr_drug_barcode": "TCGA-G2-A3IE-D36968",
    "bcr_drug_uuid": "ED0AF2E2-5F42-43D0-8D82-0BF7B8D15228",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB",
    "patient_ID": "TCGA.G2.A3IE",
    "bcr_drug_barcode": "TCGA-G2-A3IE-D36970",
    "bcr_drug_uuid": "E18F0291-65B2-48A7-9BFF-43C214FEEF5E",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB",
    "patient_ID": "TCGA.G2.A3IE",
    "bcr_drug_barcode": "TCGA-G2-A3IE-D36975",
    "bcr_drug_uuid": "EF18CA04-7D1C-4580-B62B-20451BF14EAF",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 68,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB",
    "patient_ID": "TCGA.G2.A3IE",
    "bcr_drug_barcode": "TCGA-G2-A3IE-D36977",
    "bcr_drug_uuid": "B7D591DE-0ACE-4254-AA10-A217C5B92575",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB",
    "patient_ID": "TCGA.G2.A3IE",
    "bcr_drug_barcode": "TCGA-G2-A3IE-D36978",
    "bcr_drug_uuid": "A871439A-808A-4E69-A22A-014DB1C06E0A",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB",
    "patient_ID": "TCGA.G2.A3IE",
    "bcr_drug_barcode": "TCGA-G2-A3IE-D36980",
    "bcr_drug_uuid": "E6E275FF-BDEA-4F7A-B8DA-3579D9A765F8",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C65BA2B8-E867-42E8-BBD0-C2CDF5130CFB",
    "patient_ID": "TCGA.G2.A3IE",
    "bcr_drug_barcode": "TCGA-G2-A3IE-D36983",
    "bcr_drug_uuid": "70591683-FCF3-48E0-8E19-6D1559B9419D",
    "form_completion_date": "2012-11-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 81,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 100,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CD50C69F-0F45-4C57-B61A-8C6B41AB4F7E",
    "patient_ID": "TCGA.G2.A3VY",
    "bcr_drug_barcode": "TCGA-G2-A3VY-D66242",
    "bcr_drug_uuid": "7EDDA9A9-E287-44DC-91CE-A32E0E70B88D",
    "form_completion_date": "2014-10-6",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 210,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 210,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C04CC413-95B0-4B56-AF55-9596A5EAD4A6",
    "patient_ID": "TCGA.G2.AA3C",
    "bcr_drug_barcode": "TCGA-G2-AA3C-D62137",
    "bcr_drug_uuid": "FDF7A539-5619-45CA-8915-57C16EE5D42E",
    "form_completion_date": "2014-7-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C04CC413-95B0-4B56-AF55-9596A5EAD4A6",
    "patient_ID": "TCGA.G2.AA3C",
    "bcr_drug_barcode": "TCGA-G2-AA3C-D62138",
    "bcr_drug_uuid": "FB9A4401-CFEB-4B78-ABD2-AC6B25A42295",
    "form_completion_date": "2014-7-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1540865-69C2-4B60-A78E-97D0CE2957DC",
    "patient_ID": "TCGA.G2.AA3D",
    "bcr_drug_barcode": "TCGA-G2-AA3D-D64839",
    "bcr_drug_uuid": "3B181732-907C-4A8B-ACFB-C2287A106CA5",
    "form_completion_date": "2014-9-12",
    "pharmaceutical_therapy_drug_name": "TARCEVA",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 15,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 35,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "E1540865-69C2-4B60-A78E-97D0CE2957DC",
    "patient_ID": "TCGA.G2.AA3D",
    "bcr_drug_barcode": "TCGA-G2-AA3D-D64842",
    "bcr_drug_uuid": "856A8F22-E5B2-4D1D-8FF4-71A85E8004F7",
    "form_completion_date": "2014-9-12",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1540865-69C2-4B60-A78E-97D0CE2957DC",
    "patient_ID": "TCGA.G2.AA3D",
    "bcr_drug_barcode": "TCGA-G2-AA3D-D64845",
    "bcr_drug_uuid": "F77B4195-85D3-48AD-81A1-8574236272DE",
    "form_completion_date": "2014-9-12",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1540865-69C2-4B60-A78E-97D0CE2957DC",
    "patient_ID": "TCGA.G2.AA3D",
    "bcr_drug_barcode": "TCGA-G2-AA3D-D64846",
    "bcr_drug_uuid": "C2128A11-E854-4827-A6D6-504653DCA925",
    "form_completion_date": "2014-9-12",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E1540865-69C2-4B60-A78E-97D0CE2957DC",
    "patient_ID": "TCGA.G2.AA3D",
    "bcr_drug_barcode": "TCGA-G2-AA3D-D64847",
    "bcr_drug_uuid": "7CFD35E6-3228-419D-9266-FA974BB82E8F",
    "form_completion_date": "2014-9-12",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 178,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9883C38F-87BF-4421-BFC0-1B1001F8159C",
    "patient_ID": "TCGA.G2.AA3F",
    "bcr_drug_barcode": "TCGA-G2-AA3F-D71336",
    "bcr_drug_uuid": "AED7E12F-8A43-4630-87A9-9366CCD4D04E",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "METHOTREXATE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9883C38F-87BF-4421-BFC0-1B1001F8159C",
    "patient_ID": "TCGA.G2.AA3F",
    "bcr_drug_barcode": "TCGA-G2-AA3F-D71338",
    "bcr_drug_uuid": "E5AF71CF-5C34-4A39-82EB-2923D31956B4",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "VINBLASTINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9883C38F-87BF-4421-BFC0-1B1001F8159C",
    "patient_ID": "TCGA.G2.AA3F",
    "bcr_drug_barcode": "TCGA-G2-AA3F-D71339",
    "bcr_drug_uuid": "C3D86C6B-69FE-4161-A290-F5EA18182DA5",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9883C38F-87BF-4421-BFC0-1B1001F8159C",
    "patient_ID": "TCGA.G2.AA3F",
    "bcr_drug_barcode": "TCGA-G2-AA3F-D71340",
    "bcr_drug_uuid": "C72DF01F-E6DA-497E-BD93-20A799528BA7",
    "form_completion_date": "2015-3-24",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 5,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 54,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4D323B18-CE5A-4516-862D-7ED1FDF1F008",
    "patient_ID": "TCGA.GC.A3YS",
    "bcr_drug_barcode": "TCGA-GC-A3YS-D64044",
    "bcr_drug_uuid": "FFFA5369-7D67-40A5-A120-A4CD5588F4B7",
    "form_completion_date": "2014-8-25",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4D323B18-CE5A-4516-862D-7ED1FDF1F008",
    "patient_ID": "TCGA.GC.A3YS",
    "bcr_drug_barcode": "TCGA-GC-A3YS-D64046",
    "bcr_drug_uuid": "F4260A3B-FA17-4169-8CF2-0CBDDD5FE2AF",
    "form_completion_date": "2014-8-25",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 73,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 106,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "4D323B18-CE5A-4516-862D-7ED1FDF1F008",
    "patient_ID": "TCGA.GC.A3YS",
    "bcr_drug_barcode": "TCGA-GC-A3YS-D64047",
    "bcr_drug_uuid": "2E38DC3B-C361-45E6-B640-4FF41CEC51DD",
    "form_completion_date": "2014-8-25",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 106,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 146,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5D54C742-5A8E-4C40-8D62-95E75E210AB8",
    "patient_ID": "TCGA.GD.A2C5",
    "bcr_drug_barcode": "TCGA-GD-A2C5-D21668",
    "bcr_drug_uuid": "E55E5EFA-886B-459C-BACD-30859695AE33",
    "form_completion_date": "2012-2-17",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 111,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 325,
    "therapy_regimen": "PROGRESSION"
  },
  {
    "bcr_patient_uuid": "5D54C742-5A8E-4C40-8D62-95E75E210AB8",
    "patient_ID": "TCGA.GD.A2C5",
    "bcr_drug_barcode": "TCGA-GD-A2C5-D31662",
    "bcr_drug_uuid": "934CEF5B-A32A-4796-90C2-2EB0E33593C0",
    "form_completion_date": "2012-5-8",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5D54C742-5A8E-4C40-8D62-95E75E210AB8",
    "patient_ID": "TCGA.GD.A2C5",
    "bcr_drug_barcode": "TCGA-GD-A2C5-D34374",
    "bcr_drug_uuid": "BFB231DE-4113-4AE6-98CF-863E2E907185",
    "form_completion_date": "2012-8-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5D54C742-5A8E-4C40-8D62-95E75E210AB8",
    "patient_ID": "TCGA.GD.A2C5",
    "bcr_drug_barcode": "TCGA-GD-A2C5-D34375",
    "bcr_drug_uuid": "C6AAC7EF-6287-4CDF-8C36-55E7DEAB91F1",
    "form_completion_date": "2012-8-13",
    "pharmaceutical_therapy_drug_name": "FOSAPREPITANT",
    "days_to_drug_start": 327,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A41B7D4-132F-4FB6-87B5-487C445379C7",
    "patient_ID": "TCGA.GD.A3OS",
    "bcr_drug_barcode": "TCGA-GD-A3OS-D33555",
    "bcr_drug_uuid": "5BF7C585-9318-4F70-B0B9-AFE400CEDF99",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A41B7D4-132F-4FB6-87B5-487C445379C7",
    "patient_ID": "TCGA.GD.A3OS",
    "bcr_drug_barcode": "TCGA-GD-A3OS-D33556",
    "bcr_drug_uuid": "DCA7681A-7E25-43B0-958E-02E18C6D3A9C",
    "form_completion_date": "2012-7-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 58,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 156,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "2A41B7D4-132F-4FB6-87B5-487C445379C7",
    "patient_ID": "TCGA.GD.A3OS",
    "bcr_drug_barcode": "TCGA-GD-A3OS-D42522",
    "bcr_drug_uuid": "ACBC4B23-5E53-4C87-B64E-6EB9D530A59F",
    "form_completion_date": "2013-4-23",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 499,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 549,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0691B8C5-6244-407C-8601-FA1BDA01FF2A",
    "patient_ID": "TCGA.GU.A42R",
    "bcr_drug_barcode": "TCGA-GU-A42R-D66344",
    "bcr_drug_uuid": "37B5BF80-1114-4AC1-A162-AEA65A922BFD",
    "form_completion_date": "2014-10-10",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 344,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0691B8C5-6244-407C-8601-FA1BDA01FF2A",
    "patient_ID": "TCGA.GU.A42R",
    "bcr_drug_barcode": "TCGA-GU-A42R-D66345",
    "bcr_drug_uuid": "AC9DC3F1-BB17-4D91-B956-0AB30EF5F8AD",
    "form_completion_date": "2014-10-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 105,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 344,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3D644EAF-82FC-4BC7-93B7-3E600E8C6511",
    "patient_ID": "TCGA.GV.A3JW",
    "bcr_drug_barcode": "TCGA-GV-A3JW-D41958",
    "bcr_drug_uuid": "468BA57F-D035-4485-AACC-4B98C6DA1D64",
    "form_completion_date": "2013-4-8",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 291,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "3D644EAF-82FC-4BC7-93B7-3E600E8C6511",
    "patient_ID": "TCGA.GV.A3JW",
    "bcr_drug_barcode": "TCGA-GV-A3JW-D41960",
    "bcr_drug_uuid": "2D58D7E3-0704-4B8C-9F30-70D128D38753",
    "form_completion_date": "2013-4-8",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 291,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 321,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9CC92795-7A24-4875-87F0-3EFCCBFCC970",
    "patient_ID": "TCGA.GV.A3JZ",
    "bcr_drug_barcode": "TCGA-GV-A3JZ-D41963",
    "bcr_drug_uuid": "65B99415-8F16-4D70-A4AE-11936DC426D0",
    "form_completion_date": "2013-4-8",
    "clinical_trial_drug_classification": "CHEMOTHERAPY",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 529,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 589,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "47990D5E-A0E1-4752-86F5-4F5B84E219DF",
    "patient_ID": "TCGA.GV.A3QF",
    "bcr_drug_barcode": "TCGA-GV-A3QF-D34428",
    "bcr_drug_uuid": "C3084EB0-5C6B-4C02-8C48-9A1153E1241B",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 246,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "47990D5E-A0E1-4752-86F5-4F5B84E219DF",
    "patient_ID": "TCGA.GV.A3QF",
    "bcr_drug_barcode": "TCGA-GV-A3QF-D34429",
    "bcr_drug_uuid": "9B75FBD1-AA78-46F4-A764-2940950BAF52",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 197,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 261,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5",
    "patient_ID": "TCGA.GV.A3QH",
    "bcr_drug_barcode": "TCGA-GV-A3QH-D34426",
    "bcr_drug_uuid": "9CF70C19-B60F-494B-948B-D1E6355C2A91",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "CDDP",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "33BC6A7C-9844-41E3-96B3-1E34BB3FEDD5",
    "patient_ID": "TCGA.GV.A3QH",
    "bcr_drug_barcode": "TCGA-GV-A3QH-D34427",
    "bcr_drug_uuid": "31442F55-E1D1-40C8-B27E-2AF7845AC2BF",
    "form_completion_date": "2012-8-14",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 170,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "06F936E9-5A90-40D3-B91A-713F2B4E6E11",
    "patient_ID": "TCGA.GV.A3QI",
    "bcr_drug_barcode": "TCGA-GV-A3QI-D68565",
    "bcr_drug_uuid": "94144F45-DE4A-4761-ACAA-075FEFF890D8",
    "form_completion_date": "2014-11-26",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 771,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 895,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9EE8E704-C61D-413D-B69D-257EF829FDAE",
    "patient_ID": "TCGA.GV.A3QK",
    "bcr_drug_barcode": "TCGA-GV-A3QK-D35602",
    "bcr_drug_uuid": "C74D30C4-190A-42DE-9532-944A0DAD0793",
    "form_completion_date": "2012-10-3",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9EE8E704-C61D-413D-B69D-257EF829FDAE",
    "patient_ID": "TCGA.GV.A3QK",
    "bcr_drug_barcode": "TCGA-GV-A3QK-D35603",
    "bcr_drug_uuid": "21762143-7F76-4C09-B8A0-708E0368877E",
    "form_completion_date": "2012-10-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 126,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AA6142AF-BAD7-493C-98A0-FD070DE39073",
    "patient_ID": "TCGA.GV.A40E",
    "bcr_drug_barcode": "TCGA-GV-A40E-D46771",
    "bcr_drug_uuid": "80544398-4595-44E5-9650-9587BA3A39A8",
    "form_completion_date": "2013-9-9",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AA6142AF-BAD7-493C-98A0-FD070DE39073",
    "patient_ID": "TCGA.GV.A40E",
    "bcr_drug_barcode": "TCGA-GV-A40E-D46772",
    "bcr_drug_uuid": "33632558-830A-43A8-90A6-7E36DF5AE959",
    "form_completion_date": "2013-9-9",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 98,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "353C5FCC-9C6A-4AC6-99DC-FB4573B2AE6C",
    "patient_ID": "TCGA.HQ.A2OE",
    "bcr_drug_barcode": "TCGA-HQ-A2OE-D34458",
    "bcr_drug_uuid": "3754F06A-C313-4AE5-80B9-06DB74337512",
    "form_completion_date": "2012-10-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131
  },
  {
    "bcr_patient_uuid": "353C5FCC-9C6A-4AC6-99DC-FB4573B2AE6C",
    "patient_ID": "TCGA.HQ.A2OE",
    "bcr_drug_barcode": "TCGA-HQ-A2OE-D34465",
    "bcr_drug_uuid": "513FCD32-09D2-4E51-B3A5-26F80E568B31",
    "form_completion_date": "2012-10-2",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 56,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 131
  },
  {
    "bcr_patient_uuid": "661D7B4A-A2B2-4251-B464-292421665948",
    "patient_ID": "TCGA.K4.A6MB",
    "bcr_drug_barcode": "TCGA-K4-A6MB-D64000",
    "bcr_drug_uuid": "0ACB6707-63B4-4FDD-AAAC-70511B8F5519",
    "form_completion_date": "2014-8-26",
    "pharmaceutical_tx_ongoing_indicator": false,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AA14FFB4-A715-4636-8251-73D019DDDD8C",
    "patient_ID": "TCGA.K4.A83P",
    "bcr_drug_barcode": "TCGA-K4-A83P-D70489",
    "bcr_drug_uuid": "1BE668A8-CB1C-4D9C-A2B8-0993CA43A4D9",
    "form_completion_date": "2015-2-18",
    "pharmaceutical_therapy_drug_name": "CARBOPLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "AA14FFB4-A715-4636-8251-73D019DDDD8C",
    "patient_ID": "TCGA.K4.A83P",
    "bcr_drug_barcode": "TCGA-K4-A83P-D70495",
    "bcr_drug_uuid": "D954A0C1-B175-485D-837F-4B0E004DB01A",
    "form_completion_date": "2015-2-18",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "383BF27A-9216-492E-B4BD-2B4EEF8278DE",
    "patient_ID": "TCGA.K4.AAQO",
    "bcr_drug_barcode": "TCGA-K4-AAQO-D64606",
    "bcr_drug_uuid": "2ABB2BC6-099E-4E45-9270-AD1FE8B8D172",
    "form_completion_date": "2014-9-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "383BF27A-9216-492E-B4BD-2B4EEF8278DE",
    "patient_ID": "TCGA.K4.AAQO",
    "bcr_drug_barcode": "TCGA-K4-AAQO-D64607",
    "bcr_drug_uuid": "132A555E-0765-4E61-A452-ACC71978BE5E",
    "form_completion_date": "2014-9-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "days_to_drug_start": 120,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 181,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D7AF7E2C-F742-46ED-814B-1967D7E8C2D2",
    "patient_ID": "TCGA.KQ.A41P",
    "bcr_drug_barcode": "TCGA-KQ-A41P-D72534",
    "bcr_drug_uuid": "D447E690-1351-4ED4-9FF8-FFBCDB320B4F",
    "form_completion_date": "2015-7-13",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D7AF7E2C-F742-46ED-814B-1967D7E8C2D2",
    "patient_ID": "TCGA.KQ.A41P",
    "bcr_drug_barcode": "TCGA-KQ-A41P-D72535",
    "bcr_drug_uuid": "15643365-9F58-4E83-AF6D-8824F59E4EDD",
    "form_completion_date": "2015-7-13",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 189,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 331,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EC7FC492-53CC-4B71-A66A-1CEF1ADEBA33",
    "patient_ID": "TCGA.LT.A5Z6",
    "bcr_drug_barcode": "TCGA-LT-A5Z6-D43759",
    "bcr_drug_uuid": "92EF1CC6-534C-4021-ADF7-5DF2B386E56F",
    "form_completion_date": "2013-6-3",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EC7FC492-53CC-4B71-A66A-1CEF1ADEBA33",
    "patient_ID": "TCGA.LT.A5Z6",
    "bcr_drug_barcode": "TCGA-LT-A5Z6-D45446",
    "bcr_drug_uuid": "822C656A-0E82-4336-A8C3-5771FBBDC47D",
    "form_completion_date": "2013-7-15",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 29,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7D198EE2-D80A-4759-804F-A7EF85971843",
    "patient_ID": "TCGA.SY.A9G5",
    "bcr_drug_barcode": "TCGA-SY-A9G5-D66296",
    "bcr_drug_uuid": "B16969E0-B6D0-45A5-BBE2-2BED7B62C63B",
    "form_completion_date": "2014-10-8",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "7D198EE2-D80A-4759-804F-A7EF85971843",
    "patient_ID": "TCGA.SY.A9G5",
    "bcr_drug_barcode": "TCGA-SY-A9G5-D66297",
    "bcr_drug_uuid": "5099B55A-B4B4-4D54-B510-43CBC090970D",
    "form_completion_date": "2014-10-8",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 83,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 145,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "D46F7976-6061-4CA9-8294-6C215703662B",
    "patient_ID": "TCGA.UY.A78L",
    "bcr_drug_barcode": "TCGA-UY-A78L-D68687",
    "bcr_drug_uuid": "233EC6CE-DA51-400F-8878-827ECA237236",
    "form_completion_date": "2014-12-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "D46F7976-6061-4CA9-8294-6C215703662B",
    "patient_ID": "TCGA.UY.A78L",
    "bcr_drug_barcode": "TCGA-UY-A78L-D69856",
    "bcr_drug_uuid": "0E39EA87-108E-4729-AE4A-09934E78A61C",
    "form_completion_date": "2015-1-21",
    "pharmaceutical_therapy_drug_name": "CISPLATNIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 152,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 232,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "FE33E5E0-A54D-481A-897C-E32B4708DA69",
    "patient_ID": "TCGA.UY.A8OB",
    "bcr_drug_barcode": "TCGA-UY-A8OB-D70404",
    "bcr_drug_uuid": "69B088FE-1097-4781-BCC0-EF0EA698B9DC",
    "form_completion_date": "2015-2-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "FE33E5E0-A54D-481A-897C-E32B4708DA69",
    "patient_ID": "TCGA.UY.A8OB",
    "bcr_drug_barcode": "TCGA-UY-A8OB-D71221",
    "bcr_drug_uuid": "75DB2664-316D-409E-BF69-FB0D747D9638",
    "form_completion_date": "2015-3-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "EED3908F-F1BD-4254-BCA8-BC1A7427E95C",
    "patient_ID": "TCGA.XF.A8HI",
    "bcr_drug_barcode": "TCGA-XF-A8HI-D56265",
    "bcr_drug_uuid": "A25AFABE-9CE2-4884-8B35-F3B678CF3ECE",
    "form_completion_date": "2014-3-13",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 544,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B838A4DB-EF0A-4D88-A220-BF57E31E0B3C",
    "patient_ID": "TCGA.XF.A9SH",
    "bcr_drug_barcode": "TCGA-XF-A9SH-D60614",
    "bcr_drug_uuid": "7C8A6B39-2A32-46E1-AADF-5A6241BDE19F",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "HALICHONDRIN B",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 625,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 996,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B838A4DB-EF0A-4D88-A220-BF57E31E0B3C",
    "patient_ID": "TCGA.XF.A9SH",
    "bcr_drug_barcode": "TCGA-XF-A9SH-D60615",
    "bcr_drug_uuid": "5E4B3CA0-F30A-4AB4-92B0-21CE18C5F673",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1633,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1680,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "B838A4DB-EF0A-4D88-A220-BF57E31E0B3C",
    "patient_ID": "TCGA.XF.A9SH",
    "bcr_drug_barcode": "TCGA-XF-A9SH-D60616",
    "bcr_drug_uuid": "E6E517CD-69CD-47B1-A37C-3E391358760C",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1759,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1782,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B838A4DB-EF0A-4D88-A220-BF57E31E0B3C",
    "patient_ID": "TCGA.XF.A9SH",
    "bcr_drug_barcode": "TCGA-XF-A9SH-D60617",
    "bcr_drug_uuid": "69B4DD39-6085-4AD4-AF71-2BAD0CC5C38C",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "DOXORUBICIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1759,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1782,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "B838A4DB-EF0A-4D88-A220-BF57E31E0B3C",
    "patient_ID": "TCGA.XF.A9SH",
    "bcr_drug_barcode": "TCGA-XF-A9SH-D60618",
    "bcr_drug_uuid": "DF017D1D-16C0-43F6-94AB-B00A20C21B55",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "MESNA",
    "pharmaceutical_therapy_type": "ANCILLARY",
    "days_to_drug_start": 1759,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1782,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03F588D6-832E-47D8-A9C4-AF6640A1A635",
    "patient_ID": "TCGA.XF.A9SK",
    "bcr_drug_barcode": "TCGA-XF-A9SK-D56757",
    "bcr_drug_uuid": "CA01F02D-27E1-4691-84DB-C85358D13EDE",
    "form_completion_date": "2014-2-24",
    "pharmaceutical_therapy_drug_name": "BCG, INTRAVESICULAR",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": -368,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03F588D6-832E-47D8-A9C4-AF6640A1A635",
    "patient_ID": "TCGA.XF.A9SK",
    "bcr_drug_barcode": "TCGA-XF-A9SK-D59547",
    "bcr_drug_uuid": "AFD80131-BB45-4B48-8FDA-D8DD17DB58E5",
    "form_completion_date": "2014-8-25",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 304,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "03F588D6-832E-47D8-A9C4-AF6640A1A635",
    "patient_ID": "TCGA.XF.A9SK",
    "bcr_drug_barcode": "TCGA-XF-A9SK-D59548",
    "bcr_drug_uuid": "C5CAB0B3-D160-40EC-B953-DC062772B140",
    "form_completion_date": "2014-8-25",
    "pharmaceutical_therapy_drug_name": "PLATINOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 142,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 304,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42BCF1A7-2F3A-4ED8-A41D-CDD67E65B928",
    "patient_ID": "TCGA.XF.A9SU",
    "bcr_drug_barcode": "TCGA-XF-A9SU-D59904",
    "bcr_drug_uuid": "BFE57565-B6DD-447B-81D7-F7D6FA898FCE",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "42BCF1A7-2F3A-4ED8-A41D-CDD67E65B928",
    "patient_ID": "TCGA.XF.A9SU",
    "bcr_drug_barcode": "TCGA-XF-A9SU-D59905",
    "bcr_drug_uuid": "D6E029D5-9B39-43B5-A982-1DBEA353A1EE",
    "form_completion_date": "2014-6-16",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 137,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 137,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CDFD86DB-15E2-4D38-A717-2207E8DE2D8F",
    "patient_ID": "TCGA.XF.A9SV",
    "bcr_drug_barcode": "TCGA-XF-A9SV-D56790",
    "bcr_drug_uuid": "596F516C-004B-4C0B-B076-4D3E4BAB175D",
    "form_completion_date": "2014-2-20",
    "pharmaceutical_therapy_drug_name": "BCG",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CDFD86DB-15E2-4D38-A717-2207E8DE2D8F",
    "patient_ID": "TCGA.XF.A9SV",
    "bcr_drug_barcode": "TCGA-XF-A9SV-D60792",
    "bcr_drug_uuid": "DD1352CC-3227-4F0F-A511-88FD346D3CEF",
    "form_completion_date": "2014-7-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CDFD86DB-15E2-4D38-A717-2207E8DE2D8F",
    "patient_ID": "TCGA.XF.A9SV",
    "bcr_drug_barcode": "TCGA-XF-A9SV-D60793",
    "bcr_drug_uuid": "20BA299F-7C25-4BC2-BB4F-565932294B6A",
    "form_completion_date": "2014-7-5",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 174,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 208,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CDFD86DB-15E2-4D38-A717-2207E8DE2D8F",
    "patient_ID": "TCGA.XF.A9SV",
    "bcr_drug_barcode": "TCGA-XF-A9SV-D60794",
    "bcr_drug_uuid": "D5A60CFA-05F5-4600-BA8F-F5B8C3108D20",
    "form_completion_date": "2014-7-5",
    "pharmaceutical_therapy_drug_name": "SAHA/VORINOSTAT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 258,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 342,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "A648D9BF-CF37-41FC-9515-E8F5AC85FCD4",
    "patient_ID": "TCGA.XF.A9SX",
    "bcr_drug_barcode": "TCGA-XF-A9SX-D61323",
    "bcr_drug_uuid": "33DFE922-C183-4518-A06C-6CB9DD506E92",
    "form_completion_date": "2014-7-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "A648D9BF-CF37-41FC-9515-E8F5AC85FCD4",
    "patient_ID": "TCGA.XF.A9SX",
    "bcr_drug_barcode": "TCGA-XF-A9SX-D61325",
    "bcr_drug_uuid": "2B62B01D-0739-459F-A8CF-09AB969D0727",
    "form_completion_date": "2014-7-5",
    "pharmaceutical_therapy_drug_name": "PLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 136,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 348,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A83F744-8469-41EF-A4CD-E983F849383F",
    "patient_ID": "TCGA.XF.A9SY",
    "bcr_drug_barcode": "TCGA-XF-A9SY-D61329",
    "bcr_drug_uuid": "9B51FD68-FAD7-4443-99BA-9C30ABC2158A",
    "form_completion_date": "2014-7-5",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 199,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8A83F744-8469-41EF-A4CD-E983F849383F",
    "patient_ID": "TCGA.XF.A9SY",
    "bcr_drug_barcode": "TCGA-XF-A9SY-D61330",
    "bcr_drug_uuid": "FF865837-071F-4A5F-A0FE-293C5CD41B14",
    "form_completion_date": "2014-7-5",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 199,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 256,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DC321B92-7275-48C9-ADEB-7670DB3195EF",
    "patient_ID": "TCGA.XF.A9SZ",
    "bcr_drug_barcode": "TCGA-XF-A9SZ-D61362",
    "bcr_drug_uuid": "B5C1A628-866C-470D-BA8A-0F7C97FCC91D",
    "form_completion_date": "2014-6-27",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "DC321B92-7275-48C9-ADEB-7670DB3195EF",
    "patient_ID": "TCGA.XF.A9SZ",
    "bcr_drug_barcode": "TCGA-XF-A9SZ-D61363",
    "bcr_drug_uuid": "4AF3BF48-56AA-4F54-B844-FEE9CA96906F",
    "form_completion_date": "2014-6-27",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 97,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 169,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9A03EAA-A228-429C-99C5-8E877379DB0F",
    "patient_ID": "TCGA.XF.A9T4",
    "bcr_drug_barcode": "TCGA-XF-A9T4-D61598",
    "bcr_drug_uuid": "8569E177-53CE-4F0A-A13B-A91033FBCA52",
    "form_completion_date": "2014-7-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9A03EAA-A228-429C-99C5-8E877379DB0F",
    "patient_ID": "TCGA.XF.A9T4",
    "bcr_drug_barcode": "TCGA-XF-A9T4-D61599",
    "bcr_drug_uuid": "37732A8A-3221-43E0-9005-D6DD476681B4",
    "form_completion_date": "2014-7-1",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 158,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 281,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9A03EAA-A228-429C-99C5-8E877379DB0F",
    "patient_ID": "TCGA.XF.A9T4",
    "bcr_drug_barcode": "TCGA-XF-A9T4-D61600",
    "bcr_drug_uuid": "C7B176F7-AE11-4554-9D9E-BE4ACD7E4D05",
    "form_completion_date": "2014-7-1",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 402,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 436,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9A03EAA-A228-429C-99C5-8E877379DB0F",
    "patient_ID": "TCGA.XF.A9T4",
    "bcr_drug_barcode": "TCGA-XF-A9T4-D61601",
    "bcr_drug_uuid": "4202EF5B-25B9-4985-A80C-D178F51C37CE",
    "form_completion_date": "2014-7-1",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 402,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 436,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9A03EAA-A228-429C-99C5-8E877379DB0F",
    "patient_ID": "TCGA.XF.A9T4",
    "bcr_drug_barcode": "TCGA-XF-A9T4-D61602",
    "bcr_drug_uuid": "566FD975-165D-48C5-B55E-F799C2467205",
    "form_completion_date": "2014-7-1",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 402,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 436,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9A7AB94-70DF-4194-8102-66021D01DADD",
    "patient_ID": "TCGA.XF.A9T5",
    "bcr_drug_barcode": "TCGA-XF-A9T5-D61658",
    "bcr_drug_uuid": "5A0BF7D9-C1D3-40C8-A743-08C9DC439BFD",
    "form_completion_date": "2014-7-2",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 687,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 757,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "F9A7AB94-70DF-4194-8102-66021D01DADD",
    "patient_ID": "TCGA.XF.A9T5",
    "bcr_drug_barcode": "TCGA-XF-A9T5-D61661",
    "bcr_drug_uuid": "4CD8075E-9FC3-4BC0-854E-7E1757A94428",
    "form_completion_date": "2014-7-2",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 687,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 757,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C8388AC0-975D-4F1E-8324-8CABDC75738D",
    "patient_ID": "TCGA.XF.AAME",
    "bcr_drug_barcode": "TCGA-XF-AAME-D62017",
    "bcr_drug_uuid": "F30604A8-2DC5-41A4-94B1-ECCF7B8E8D50",
    "form_completion_date": "2014-7-11",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2569,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2569,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C8388AC0-975D-4F1E-8324-8CABDC75738D",
    "patient_ID": "TCGA.XF.AAME",
    "bcr_drug_barcode": "TCGA-XF-AAME-D62018",
    "bcr_drug_uuid": "5C2FA8E7-E9CB-4A48-96B8-95A7693E491C",
    "form_completion_date": "2014-7-11",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2500,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2543,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C8388AC0-975D-4F1E-8324-8CABDC75738D",
    "patient_ID": "TCGA.XF.AAME",
    "bcr_drug_barcode": "TCGA-XF-AAME-D62019",
    "bcr_drug_uuid": "74172342-04F3-4F20-A105-7C8E9E7332EF",
    "form_completion_date": "2014-7-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 2500,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 2543,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93FBE302-A2E0-4CF4-A638-312786F547C2",
    "patient_ID": "TCGA.XF.AAMF",
    "bcr_drug_barcode": "TCGA-XF-AAMF-D62164",
    "bcr_drug_uuid": "34818ACA-D38D-4BCB-AEB2-E0EE140B02F9",
    "form_completion_date": "2014-7-12",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "93FBE302-A2E0-4CF4-A638-312786F547C2",
    "patient_ID": "TCGA.XF.AAMF",
    "bcr_drug_barcode": "TCGA-XF-AAMF-D62165",
    "bcr_drug_uuid": "B24DCE72-D14C-46B8-BDA3-F31C0BFC76E0",
    "form_completion_date": "2014-7-12",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 161,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 274,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "390A29FE-2CFD-43C4-A247-69E692763E17",
    "patient_ID": "TCGA.XF.AAMG",
    "bcr_drug_barcode": "TCGA-XF-AAMG-D61740",
    "bcr_drug_uuid": "0EFF6E6D-4AC0-42E3-BBAC-B0E7F4EA0976",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "390A29FE-2CFD-43C4-A247-69E692763E17",
    "patient_ID": "TCGA.XF.AAMG",
    "bcr_drug_barcode": "TCGA-XF-AAMG-D61739",
    "bcr_drug_uuid": "8B357F3E-0BE3-4DFF-86E8-14A7AB8F41DA",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 74,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 151,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8F10E006-531A-49AC-B51B-DF3FDCB20929",
    "patient_ID": "TCGA.XF.AAMJ",
    "bcr_drug_barcode": "TCGA-XF-AAMJ-D62171",
    "bcr_drug_uuid": "D68B731D-FAF0-437A-957F-045178B96A76",
    "form_completion_date": "2014-7-12",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "8F10E006-531A-49AC-B51B-DF3FDCB20929",
    "patient_ID": "TCGA.XF.AAMJ",
    "bcr_drug_barcode": "TCGA-XF-AAMJ-D62172",
    "bcr_drug_uuid": "CDEADBEB-7461-4531-8F71-3CADA30D810F",
    "form_completion_date": "2014-7-12",
    "pharmaceutical_therapy_drug_name": "PLATINUM",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 82,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 143,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "818F5A45-4DEB-49E4-9A73-55EF4269DE4C",
    "patient_ID": "TCGA.XF.AAMR",
    "bcr_drug_barcode": "TCGA-XF-AAMR-D62176",
    "bcr_drug_uuid": "DC0734AB-1A00-4F51-B45A-79BBC93ECFD4",
    "form_completion_date": "2014-7-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "818F5A45-4DEB-49E4-9A73-55EF4269DE4C",
    "patient_ID": "TCGA.XF.AAMR",
    "bcr_drug_barcode": "TCGA-XF-AAMR-D62177",
    "bcr_drug_uuid": "9D981374-EAE9-42D6-A165-E82DAB559C5C",
    "form_completion_date": "2014-7-13",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 119,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 192,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D2B19EB-BD61-490E-982B-FADF2C4AADF7",
    "patient_ID": "TCGA.XF.AAMY",
    "bcr_drug_barcode": "TCGA-XF-AAMY-D62220",
    "bcr_drug_uuid": "A1380301-5B3D-4542-A8FE-04A142DA42A0",
    "form_completion_date": "2014-7-15",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 669,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 853,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D2B19EB-BD61-490E-982B-FADF2C4AADF7",
    "patient_ID": "TCGA.XF.AAMY",
    "bcr_drug_barcode": "TCGA-XF-AAMY-D62221",
    "bcr_drug_uuid": "A03EFBED-7200-459C-BD63-8118F79AA905",
    "form_completion_date": "2014-7-15",
    "pharmaceutical_therapy_drug_name": "CARBOPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 671,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 853,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "ED36D054-53C4-465C-BD84-6EC5227097BF",
    "patient_ID": "TCGA.XF.AAMZ",
    "bcr_drug_barcode": "TCGA-XF-AAMZ-D62345",
    "bcr_drug_uuid": "FEC38DE9-1E37-4277-B128-DE87B74E792C",
    "form_completion_date": "2014-7-15",
    "pharmaceutical_therapy_drug_name": "BCG",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62515",
    "bcr_drug_uuid": "31A1CF90-2836-422A-A78F-40F78E13C639",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 53,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62516",
    "bcr_drug_uuid": "00007185-662F-4AF9-B90F-B73DEDEAE8A7",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "PACITAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62517",
    "bcr_drug_uuid": "93A46A11-39E8-4593-AE3F-4AB50B3E623D",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 53,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 175,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62518",
    "bcr_drug_uuid": "6C3388FA-B1D4-4315-BE94-CC4E39FAB53E",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "HALICHONDRIN",
    "clinical_trial_drug_classification": "ANTI-TUBULIN AGENT",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 614,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 866,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62519",
    "bcr_drug_uuid": "B7F6E64F-1BB2-4388-AABF-F62AB860C455",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 898,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1052,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62520",
    "bcr_drug_uuid": "535127D6-B422-4608-A7D1-1B0ED7D63611",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "TAXOL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 898,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1052,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62521",
    "bcr_drug_uuid": "60FD150C-836A-4098-905F-CB879F56DF75",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 898,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1052,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62522",
    "bcr_drug_uuid": "BA0FAC90-B83B-4B17-9C03-35C0198A3273",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN (DOXORUBICIN)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1094,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1136,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62523",
    "bcr_drug_uuid": "BB3FECDF-1F45-42B9-BC18-242AB337CFE0",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1094,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1136,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62524",
    "bcr_drug_uuid": "F0FF819C-FA2C-4E7B-A1CA-8CD498BD3371",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN (DOXORUBICIN)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1265,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1318,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62525",
    "bcr_drug_uuid": "2A7E98EA-34FF-45BB-BB07-D816EF52D85B",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1265,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1318,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62526",
    "bcr_drug_uuid": "D1BB434A-F94E-4706-A788-71D092772679",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1423,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1486,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62527",
    "bcr_drug_uuid": "4E2AD69A-535F-4040-B362-1FE4451470F1",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN (DOXORUBICIN)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1465,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1486,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62528",
    "bcr_drug_uuid": "BF52CAD0-17AF-465D-B6B0-3E4368D6A4FD",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1598,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1598,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62529",
    "bcr_drug_uuid": "226B95EA-5675-4BA5-A592-3FD8A86E53C5",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "ADRIAMYCIN (DOXORUBICIN)",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1598,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1598,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62530",
    "bcr_drug_uuid": "1E22652B-7F6C-469D-BFC7-4AE593AAEEA0",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "TEMSIROLIMUS",
    "clinical_trial_drug_classification": "MTOR INHIBITOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1703,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1703,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "E7E95597-EF88-4442-8C01-8D633822E7B5",
    "patient_ID": "TCGA.XF.AAN0",
    "bcr_drug_barcode": "TCGA-XF-AAN0-D62531",
    "bcr_drug_uuid": "6B5260D5-8811-491D-A355-746EC69DD098",
    "form_completion_date": "2014-7-19",
    "pharmaceutical_therapy_drug_name": "VINORELBINE",
    "clinical_trial_drug_classification": "ANTI-MITOTIC, VINCA ALKALOID",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 1703,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 1703,
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "5378F375-AA04-4ECA-BC35-190B3EFB52BC",
    "patient_ID": "TCGA.XF.AAN1",
    "bcr_drug_barcode": "TCGA-XF-AAN1-D62347",
    "bcr_drug_uuid": "A9E44A74-1D24-42CF-B7E4-45E5EE58D785",
    "form_completion_date": "2014-7-16",
    "pharmaceutical_therapy_drug_name": "BCG",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "5378F375-AA04-4ECA-BC35-190B3EFB52BC",
    "patient_ID": "TCGA.XF.AAN1",
    "bcr_drug_barcode": "TCGA-XF-AAN1-D62348",
    "bcr_drug_uuid": "31A09893-A09C-4BE3-A64A-11D2D283BACC",
    "form_completion_date": "2014-7-16",
    "pharmaceutical_therapy_drug_name": "BCG",
    "pharmaceutical_therapy_type": "IMMUNOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 0,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "24AD2168-B25A-4DE8-A021-DFE1C74FCC6E",
    "patient_ID": "TCGA.XF.AAN3",
    "bcr_drug_barcode": "TCGA-XF-AAN3-D62344",
    "bcr_drug_uuid": "D4FB8933-FBBE-4CAB-A174-BC166465ECC7",
    "form_completion_date": "2014-7-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "24AD2168-B25A-4DE8-A021-DFE1C74FCC6E",
    "patient_ID": "TCGA.XF.AAN3",
    "bcr_drug_barcode": "TCGA-XF-AAN3-D62538",
    "bcr_drug_uuid": "DEB2649C-47A3-4709-A79E-3DBDCEEF801D",
    "form_completion_date": "2014-7-20",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 121,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 142,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1591625-E794-4155-8AE4-B74D6264659F",
    "patient_ID": "TCGA.XF.AAN5",
    "bcr_drug_barcode": "TCGA-XF-AAN5-D62542",
    "bcr_drug_uuid": "DD5FBE8B-3A35-44F8-8014-02334A3FACCA",
    "form_completion_date": "2014-7-20",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "C1591625-E794-4155-8AE4-B74D6264659F",
    "patient_ID": "TCGA.XF.AAN5",
    "bcr_drug_barcode": "TCGA-XF-AAN5-D62543",
    "bcr_drug_uuid": "9A823C6E-A86F-4A1C-A542-03795247A7A9",
    "form_completion_date": "2014-7-20",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 127,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 211,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D7FBDEB-EA3D-4E07-8527-23C5997D77CF",
    "patient_ID": "TCGA.XF.AAN7",
    "bcr_drug_barcode": "TCGA-XF-AAN7-D62544",
    "bcr_drug_uuid": "85C213D0-980A-474E-872A-1C13921AF1F4",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D7FBDEB-EA3D-4E07-8527-23C5997D77CF",
    "patient_ID": "TCGA.XF.AAN7",
    "bcr_drug_barcode": "TCGA-XF-AAN7-D62545",
    "bcr_drug_uuid": "9182B031-3872-486A-B137-38E2A151FF89",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 162,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 200,
    "treatment_best_response": "PARTIAL RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D7FBDEB-EA3D-4E07-8527-23C5997D77CF",
    "patient_ID": "TCGA.XF.AAN7",
    "bcr_drug_barcode": "TCGA-XF-AAN7-D62546",
    "bcr_drug_uuid": "F3AB0FF8-2D1F-47EB-83FA-09CF13D375EF",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "IFOSFAMIDE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 351,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 374,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D7FBDEB-EA3D-4E07-8527-23C5997D77CF",
    "patient_ID": "TCGA.XF.AAN7",
    "bcr_drug_barcode": "TCGA-XF-AAN7-D62547",
    "bcr_drug_uuid": "76A9D3F2-9A8E-4A07-8BA5-45DAC66F7D5A",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "PACLITAXEL",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 9,
    "treatment_best_response": "STABLE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D7FBDEB-EA3D-4E07-8527-23C5997D77CF",
    "patient_ID": "TCGA.XF.AAN7",
    "bcr_drug_barcode": "TCGA-XF-AAN7-D62548",
    "bcr_drug_uuid": "CF060018-E3F7-45BA-8407-8CF590D28DD6",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 0,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 9,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "9D7FBDEB-EA3D-4E07-8527-23C5997D77CF",
    "patient_ID": "TCGA.XF.AAN7",
    "bcr_drug_barcode": "TCGA-XF-AAN7-D62549",
    "bcr_drug_uuid": "0DBB730F-938A-4675-A8DE-8575ACA21C6A",
    "form_completion_date": "2014-7-21",
    "pharmaceutical_therapy_drug_name": "DOCETAXEL +/- ZACTIMA",
    "clinical_trial_drug_classification": "BLINDED: ZACTIMA OR PLACEBO. ZACTIMA IS A KINASE INHIBITOR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 399,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 442,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": true
  },
  {
    "bcr_patient_uuid": "95520295-90D3-4B4E-86B6-4BD856723315",
    "patient_ID": "TCGA.YC.A89H",
    "bcr_drug_barcode": "TCGA-YC-A89H-D66948",
    "bcr_drug_uuid": "9F434C9E-E3D8-4C44-85B2-098F5CAB7AC7",
    "form_completion_date": "2014-11-11",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "95520295-90D3-4B4E-86B6-4BD856723315",
    "patient_ID": "TCGA.YC.A89H",
    "bcr_drug_barcode": "TCGA-YC-A89H-D66947",
    "bcr_drug_uuid": "8485E45C-7B44-420A-892F-E94F0B86A2A5",
    "form_completion_date": "2014-11-11",
    "pharmaceutical_therapy_drug_name": "GEMZAR",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 35,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 83,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "661967E5-94B3-4F98-9402-6AB137893C16",
    "patient_ID": "TCGA.YF.AA3L",
    "bcr_drug_barcode": "TCGA-YF-AA3L-D59724",
    "bcr_drug_uuid": "B810C98A-9764-437A-BFDA-A4CB6A37EEF9",
    "form_completion_date": "2014-5-23",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 215,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "661967E5-94B3-4F98-9402-6AB137893C16",
    "patient_ID": "TCGA.YF.AA3L",
    "bcr_drug_barcode": "TCGA-YF-AA3L-D59725",
    "bcr_drug_uuid": "4AF60913-699B-42B6-B918-1930F7671B04",
    "form_completion_date": "2014-5-23",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 214,
    "pharmaceutical_tx_ongoing_indicator": true,
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "CCD65BC8-82EF-453E-B4BC-A005CC2262D5",
    "patient_ID": "TCGA.ZF.AA4V",
    "bcr_drug_barcode": "TCGA-ZF-AA4V-D72083",
    "bcr_drug_uuid": "ED9CC992-A9F2-41F2-9711-1747A3A1F37E",
    "form_completion_date": "2015-4-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE AND CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 202,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 265,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1029514B-A32C-4C43-A440-A5BA2709F717",
    "patient_ID": "TCGA.ZF.AA51",
    "bcr_drug_barcode": "TCGA-ZF-AA51-D72091",
    "bcr_drug_uuid": "785199D4-90BF-40CE-AEAB-A5EA5953AAA3",
    "form_completion_date": "2015-4-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "1029514B-A32C-4C43-A440-A5BA2709F717",
    "patient_ID": "TCGA.ZF.AA51",
    "bcr_drug_barcode": "TCGA-ZF-AA51-D72092",
    "bcr_drug_uuid": "097FAF51-5B92-4A4C-940C-73BE0DA86F74",
    "form_completion_date": "2015-4-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 69,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 148,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "92C6856A-B26F-4512-BBB1-8A8AFF4636AB",
    "patient_ID": "TCGA.ZF.AA53",
    "bcr_drug_barcode": "TCGA-ZF-AA53-D72088",
    "bcr_drug_uuid": "C1E16CF1-0677-4402-B05C-6A1FC943E0D5",
    "form_completion_date": "2015-4-10",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "92C6856A-B26F-4512-BBB1-8A8AFF4636AB",
    "patient_ID": "TCGA.ZF.AA53",
    "bcr_drug_barcode": "TCGA-ZF-AA53-D72089",
    "bcr_drug_uuid": "348A86EE-A088-45D5-BF2B-ABE4D6526C42",
    "form_completion_date": "2015-4-10",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 68,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 166,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DA6502C-058D-47F5-9996-8AA1D511D7E4",
    "patient_ID": "TCGA.ZF.AA58",
    "bcr_drug_barcode": "TCGA-ZF-AA58-D72102",
    "bcr_drug_uuid": "0DAABAAD-5EF1-47DF-9196-94BAEB18E3D5",
    "form_completion_date": "2015-4-13",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "0DA6502C-058D-47F5-9996-8AA1D511D7E4",
    "patient_ID": "TCGA.ZF.AA58",
    "bcr_drug_barcode": "TCGA-ZF-AA58-D72103",
    "bcr_drug_uuid": "907B197A-9F12-421F-986E-019634FFD53B",
    "form_completion_date": "2015-4-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 166,
    "pharmaceutical_tx_ongoing_indicator": false,
    "treatment_best_response": "COMPLETE RESPONSE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04477379-6C51-45D9-B9B9-D05D53B53945",
    "patient_ID": "TCGA.ZF.AA5H",
    "bcr_drug_barcode": "TCGA-ZF-AA5H-D72105",
    "bcr_drug_uuid": "9182BB2E-2590-4004-A0E1-0F826DC256B8",
    "form_completion_date": "2015-4-13",
    "pharmaceutical_therapy_drug_name": "GEMCITABINE",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  },
  {
    "bcr_patient_uuid": "04477379-6C51-45D9-B9B9-D05D53B53945",
    "patient_ID": "TCGA.ZF.AA5H",
    "bcr_drug_barcode": "TCGA-ZF-AA5H-D72106",
    "bcr_drug_uuid": "CAB786E1-619B-4568-A424-698490997C7B",
    "form_completion_date": "2015-4-13",
    "pharmaceutical_therapy_drug_name": "CISPLATIN",
    "pharmaceutical_therapy_type": "CHEMOTHERAPY",
    "days_to_drug_start": 135,
    "pharmaceutical_tx_ongoing_indicator": false,
    "days_to_drug_end": 177,
    "treatment_best_response": "PROGRESSIVE DISEASE",
    "therapy_on_clinical_trial": false
  }
]
